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Executive Summary 
 
Background 
 
Multiple Sclerosis. Multiple Sclerosis (MS) is an incurable progressive 
disease that develops when the immune system mistakenly attacks the central 
nervous system. The damage results in wide-ranging symptoms of physical 
disability and neuropsychiatric symptoms. MS effects one in 1000 people, making it 
the most common neurological disease in young adults. The progressive and 
unpredictable course of MS and threat to personal autonomy from fatigue, 
disability, and functional loss can harm the well-being of those diagnosed. People 
with MS have lower levels of well-being and higher rates of mental health problems 
than the general population, making both the treatment of mental health problems 
and the enhancement of well-being important areas in the care of people with MS. 
Enhancing Well-being. Well-being is a multidimensional construct that 
encompasses various psychological, emotional and social dimensions. Definitions 
of well-being typically include the presence of high positive affect, low negative 
affect, high life satisfaction, and the actualisation of human experience and 
potentials, such as relationships or achievements. Interventions that aim to 
cultivate well-being, as opposed to treat illness, are known as Positive Psychology 
Interventions (PPIs). PPIs use techniques designed to enhance key processes 
such as positive emotions, competence, optimism, self-acceptance and positive 
relations and have been found to effective. Benefits of the PPI approach are that it 
may be applied widely in the absence of mental health diagnoses, and that having 
high levels of well-being is a protective factor against developing future mental 
health problems. Although reducing negative symptoms is not the focus of PPIs, 
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research shows that individuals have a significant reduction in depressive and 
anxiety symptoms after treatment.  
Treating mental health problems. Psychological interventions have a 
large evidence base for treating common mental health problems such as 
depression and anxiety and can be more effective at preventing relapse than 
pharmacotherapy. There is evidence that psychological interventions are effective 
for people with MS, and may be of particular value due to effective medication 
being poorly tolerated in many people with MS. 
Self-Help Interventions. Whilst there is a large evidence base for 
psychological interventions, there is a limited number of available psychological 
therapists, and self-help interventions (SHIs) have the potential to fill the shortfall 
by providing evidence-based therapies with minimal therapist contact time. SHIs 
may be particularly relevant for people with MS because they foster a sense of 
autonomy and can be accessed from home, making them accessible for those with 
limited mobility. Whilst a large evidence base exists for SHIs in different 
populations, research suggests that the effectiveness of SHIs differs significantly 
between populations with different health conditions, emphasising the need for 
their evaluation in people with MS.   
Systematic Review 
 
Aim. A systematic review was conducted on 9th December 2018 to evaluate 
how effective psychological SHIs are for people with MS in reducing distress and 
improving well-being. 
Method. Searches of the electronic databases PubMed and PsycINFO 
were conducted using search terms related to MS, well-being, mental health, 
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mental illness and self-help. To include breadth of results, no search terms related 
to ‘intervention’ were used. Studies were included if they were controlled trials (with 
or without randomisation) that reported quantitative psychological outcome data 
following a psychological SHI in people with MS. No exclusion criteria were 
applied.  
Results. The search yielded 165 results, and 7 were eligible for the review. 
All 7 were RCTs and all SHIs were web-based. Six used a wait-list control, and one 
an active control, and three included a long-term follow-up (3, 4, and 6 months). 
Two studies evaluated versions of the same intervention. Three were pure self-help 
and four were guided self-help using email (n=2), telephone (n=1), and Skype 
(n=1) support. 
The primary focus of SHIs was fatigue (n=3), depression (n=3), and physical 
activity (n=1), and all of them were primarily based on Cognitive Behavioural 
Therapy (CBT) principles. In addition, one included PPI strategies, several included 
mindfulness, and one drew from social cognitive theory.  
SHIs designed to treat fatigue all had significant improvement in fatigue relative to 
controls with medium to large effect sizes and improved QOL, maintained at 3m 
follow-up, but not necessarily improved anxiety or depression. Of those designed to 
treat depression, only one SHI reported significant improvement in depression 
relative to controls, with a medium effect size, which also translated to improved 
QOL. Improvement in depression was maintained at 6-month follow-up. One did 
not report statistics due to a small sample, and one had significant improvement in 
both groups meaning between-group differences were non-significant. The SHI 
aimed at increasing physical activity saw significant increase in physical activity, 
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reduction in fatigue and perceived disability, and a trend towards improved anxiety 
relative to controls. 
Conclusion. The systematic review revealed that there is a paucity of 
studies evaluating SHIs in individuals with MS, and none designed to improve well-
being, anxiety, or cognitive impairment. There was heterogeneity within the 
intervention content and format, and levels of guidance offered. A trend towards 
higher effect sizes for greater guidance was observed but the number of studies 
was too small to make any firm conclusions. The promising results found in SHIs 
for fatigue supports the ongoing development and evaluation of SHIs for people 
with MS. Further research is required to determine the active ingredients of 
successful SHIs for people with MS. 
Empirical Study 
 
Aim. To evaluate the effectiveness of a pure self-help PPI for increasing 
well-being and reducing depression for people with MS. 
Background of intervention. The Goals and Planning (GAP) intervention 
is designed to increase well-being by helping individuals identify and work towards 
positive life goals through teaching goal-setting and planning skills. The techniques 
taught in GAP relate directly to the knowledge derived from the empirical literature 
that show the pursuit of chosen goals can increase well-being through providing 
structure, meaning, and sense of purpose, facilitating positive future thinking, and 
providing daily experiences of autonomy, competence, and relatedness. Certain 
skills have been shown to strengthen the positive relationship between goal striving 
and well-being, and these form the basis of GAP’s six modules: Choosing self-
concordant goals, imagining achieving those goals, having small, specific and 
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realistic planned steps towards goals, being able to adapt goal plans, and being 
able to adapt or abandon unattainable goals. In a self-help format GAP has been 
shown to increase well-being and reduce depression in community and depressed 
samples. 
This intervention may be beneficial for people with MS for several reasons. For 
example, people with MS face challenges concerning life goals due to 
unpredictable disease progression and exacerbation, and goal adjustment 
capacities are thought to be crucial for coping and adjustment among individuals 
with stressful life events such as ill health. 
Method. An RCT was conducted in which a sample of 58 participants with 
MS were randomly allocated to receive GAP (n=29) or to a WLC group (n=29). 
Measures of well-being and depression were taken at three time points; baseline, 
post-intervention, and at eight-week follow-up. After the follow-up measures, the 
WLC group were given access to GAP. Changes over time in well-being and 
depression were compared between the two groups. A 2 (treatment vs control) x 3 
(Time 1, Time 2, Time 3) repeated measures ANOVA was employed to look at 
differences between the groups. 
Recruitment. Participants were recruited through asking MS Centres and 
support groups to circulate study adverts to their members, and three MS 
organisations sharing it on social media. 122 centres and groups were contacted, 
and 57 circulated the advert. Inclusion criteria were a diagnosis of MS, fluency in 
English, and consent to inform GP of participation. No exclusion criteria were 
applied.  
Measures. Sociodemographic information was collected at baseline only, 
and the following measures at all three points: 
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Positive and Negative Affect Scale Short Form (I-PANAS-SF) yields two sub-scales 
of positive affect and negative affect. 
The Flourishing Scale (FS) measures the individual’s self-perceived success in 
areas such as relationships, self-esteem, purpose, meaning and optimism. 
The Functional Assessment of Multiple Sclerosis (FAMS) is a QOL instrument 
developed for use with people with MS covering the domains of mobility, 
symptoms, emotional well-being, general contentment, thinking/fatigue, and 
family/social well-being. 
Patient Health Questionnaire (PHQ9) measures the severity of depressive 
symptoms. 
Results.  
Missing Data. 16 (27.6%) participants had missing data from one or more 
time point, and they were significantly more likely to be in the intervention group 
rather than WLC (ꭓ² (1, N=58) = 8.63, p = .007). Multiple Imputation was used to 
manage missing data. 
Sample. Participants were mainly White (97%), female (74%), middle-aged 
(mean = 50 years, SD=11.9), with relapsing-remitting MS (53%), and had been 
diagnosed for 13 years (SD=9.5). The intervention group had had MS for 
significantly longer than those in the control group (mean difference = 5.2 years, 
t(55) = 2.13, p = .033). 
Treatment effects. The intention to treat (ITT) primary analysis yielded a 
non-significant result for group x time interactions on all outcomes. There was a 
significant decrease in depression (F(2,112) = 0.97, p = .005, ηp2 = 0.02) and 
negative affect (F(2,112) = 4.34, p = .018, ηp2= 0.07) for the whole sample over 
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time. A modified ITT analysis (n= 41) revealed a significant group x time interaction 
effect for the Family and Social well-being FAMS subscale only, with a large effect 
size (F(2, 40) = 4.65, p = .012, ηp2 = .12). 
Discussion.  
Potential explanations for the unexpected significant reduction in depression and 
NA for the whole sample is a spontaneous recovery of a highly motivated 
subsample of patients, and anticipation of receiving the intervention at the end of 
the waiting period creating hope and reduction in symptoms in the WLC. 
It was unusual that a significant increase in the Family/Social subscale of the 
FAMS found in the sensitivity analysis occurred in isolation. Possible explanations 
are that it is a chance finding from multiple testing or from case-wise deletion 
creating unequal groups, or that the study lacked power to detect changes in other 
domains.  
Potential explanations for a lack of treatment effect include MS-related variables. 
For example, cognitive symptoms and fatigue could have reduced the ability for 
participants to engage fully with the modules, and the additional challenges posed 
by MS in the pursuit and adaptation of goals could mean they require additional 
guidance in the process, for example in a guided SHI. 
Conclusion. There is no evidence that GAP in a self-help format improves 
depression for people with MS. It may improve individual’s well-being in the social 
domain for those that adhere to the program. Further research is needed before 
recommendations could be made to use GAP in the population of people with MS.  
Integration, Impact and Dissemination 
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Integration. The paucity of studies found in the systematic review 
confirmed the belief that SHIs for people with MS is an area that requires further 
research and gives value to the empirical study, that appeared to be the first of its 
kind. The limitations found in the studies in the review helped to inform the 
empirical study. For example, using a QOL measure that included both positive 
and negative factors of QOL, using two or more measures to capture different 
dimensions of well-being, reporting effect sizes for all possible results, and using 
an ITT analysis. 
Difficulties recruiting to the study were evident due to a lower than expected 
response rate, despite the advert reaching a large demographic, and the study had 
low power as a result. Rhul ethical approval only allowed for non-clinical site 
recruitment; using a pre-post RCT design with no follow-up would have relieved 
time pressure and allowed for NHS ethical approval and new recruitment from 
clinical settings to achieve a larger sample size.  
Impact. The findings overall of this thesis have highlighted a significant 
need for SHIs, especially those focussing on anxiety, cognitive symptoms, and 
increasing well-being, to be evaluated in people with MS and the importance of 
even well-established interventions to be evaluated in this population before being 
recommended. Understanding the factors associated with effectiveness, so that 
they can be incorporated into the design of future SHIs, is paramount.  
Dissemination. A plain English summary of the overall research findings 
will be provided to study participants and staff members of all participating MS 
Centres and support groups, who can become sources of continued dissemination. 
Reaching a broader audience will be sought through submission to established MS 
and well-being journals. 
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Systematic Review: How effective are self-help interventions at improving 
well-being or reducing distress for people with multiple sclerosis? 
Abstract 
 
Multiple sclerosis (MS) is a progressive neurological disease that damages the 
central nervous system, resulting in wide ranging symptoms and disability that can 
negatively impact on the mental health and well-being of those diagnosed. Many 
effective psychological interventions have been transformed into a self-help format 
(SHIs) which may be particularly relevant for people with MS because they foster a 
sense of autonomy and are accessible for those with limited mobility, but this is yet 
to be systematically reviewed. This systematic review aimed to determine how 
effective psychological SHIs are for people with MS in reducing distress and 
improving well-being. 
Searches of the electronic databases PubMed and PsycINFO were conducted 
using search terms related to MS, well-being, mental health, and self-help. The 
search yielded 165 results, and 7 were eligible for the review. All 7 were RCTs and 
all SHIs were web-based. The primary focus of SHIs was fatigue (n=3), depression 
(n=3), and physical activity (n=1). SHIs designed to treat fatigue all had positive 
significant results with medium to large effect sizes and improved QOL, but not 
necessarily improved anxiety or depression. Only 1 SHI designed to treat 
depression reported significant improvement relative to controls, with a medium 
effect size, which translated to improved QOL. The SHI aimed at increasing 
physical activity saw significant increase in physical activity, reduction in fatigue 
and perceived disability, and a trend towards improved depression and anxiety. 
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There is a paucity of studies evaluating SHIs in individuals with MS, and none 
designed to improve well-being, anxiety, or cognitive impairment. The promising 
results found in SHIs for fatigue supports the ongoing development and evaluation 
of SHIs for people with MS. Further research is required to determine the active 
ingredients of successful SHIs for people with MS. 
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Background 
 
Multiple Sclerosis 
Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous 
system, which is characterised by focal plaques of demyelination and axonal loss 
in the brain and spinal cord. In addition to focal plaques, there is global 
neurodegeneration in the brain and spinal cord (Lassmann, 2018), and the 
changes gradually result in brain tissue loss and atrophy (Mahad, Trapp, & 
Lassmann, 2015).  
It is estimated that more than two million people worldwide have MS, making it the 
among the most common causes of neurological disability in young adults (World 
Health Organisation, 2008). Most people diagnosed with MS start with a relapsing-
remitting course (RRMS), which, after several years, develops into a secondary 
progressive phase (SPMS), which progresses without periods of remission. Some 
people are diagnosed with a primary progressive form of MS (PPMS) and 
experience uninterrupted disease progression from the onset, missing the 
relapsing-remitting phase (Lublin & Reingold, 1996).The ultimate cause of MS 
remains unknown (Mahad et al., 2015). 
The neurological damage results in wide-ranging symptoms of physical disability, 
including sensory and motor loss, and neuropsychiatric symptoms including 
anxiety, depression and cognitive impairment. Unfortunately, the range of 
symptoms experienced by people with MS impacts significantly on tasks of daily 
living and quality of life (QOL), over and above those with other chronic conditions 
(Mitchell, Benito-León, González, & Rivera-Navarro, 2005).  
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As well as MS causing neuropsychiatric symptoms such as anxiety and depression 
through neural damage, the progressive and unpredictable course of MS and 
threat to personal autonomy from physical disability, can have a particularly 
negative impact on the mental health and well-being of those diagnosed (McCabe 
& McKern, 2002; Mullins et al., 2001). Equally, research has repeatedly shown that 
the presence of anxiety and depression within people with MS is associated with 
poorer health outcomes (Mohr & Cox, 2001), creating a cyclical pattern. Thus, the 
relationship between mental health problems and MS is multi‐factorial and 
complex. 
Presently, MS is an incurable condition, and although disease-modifying drugs 
exist, they are only beneficial for those with RRMS and are only moderately 
effective (Wiendl & Hohlfeld, 2009). The lack of medical interventions available 
means that non-pharmalogical interventions are especially crucial for improving the 
mental health and well-being of those diagnosed. Research has shown that over 
50% of people with MS report that they have unmet non-pharmalogical needs 
relating to MS (Lonergan et al., 2015). 
Mental Health Problems 
Research has consistently shown that people with MS have higher rates of mental 
health problems than the general population, with a recent study reporting 35% of 
people with MS having diagnosed anxiety and 31% diagnosed with depression 
(Marrie et al., 2013). As well as being associated with poorer health outcomes for 
people with MS, mental health problems severely affect QOL. Interestingly, the 
negative association between mental health problems and QOL is stronger than 
that of disease-related disability and QOL for people with MS (Kern et al., 2009), 
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making them vital areas for intervention. Despite being recognised as an important 
area in the literature, both the awareness and treatment of mental health problems 
continue to be an unmet need for people with MS in the current healthcare system 
(Rieckmann et al., 2018). 
Fortunately, psychological interventions exist to treat many of the negative factors 
associated with lower QOL in people with MS, including depression, anxiety, 
fatigue, pain and cognitive impairment, although more trials are needed to evaluate 
their efficacy in people with MS specifically (Fiest et al., 2016). Psychological 
interventions may be of particular value due to effective medication being poorly 
tolerated in many people with MS, and due to being more effective at preventing 
relapse than pharmacotherapy. In addition to treating negative symptoms, 
interventions designed to improve well-being can help individuals live a valued life 
in the presence of physical difficulties. 
 
Well-being 
Well-being is a multidimensional construct that can be thought of as feeling good 
and functioning well. Well-being and mental health problems are sometimes 
thought of as being two ends of one continuum. However, research has shown that 
despite being moderately interrelated, they are two partially separate constructs 
(Keyes, 2005). Well-being spans many dimensions, and therefore, measurement 
usually involves using several measures that cover positive affect, negative affect, 
satisfaction with life, and positive functioning. QOL instruments are often used to 
measure one aspect of well-being because they capture an individual’s satisfaction 
with the physical, psychological and social aspects of their life.  
21 
 
Positive psychological interventions (PPIs) focus on cultivating well-being and 
optimal functioning by using techniques designed to enhance key processes such 
as positive emotions, competence, optimism, self-acceptance and positive relations 
(Hone, Jarden, Schofield, & Duncan, 2014). Benefits of the PPI approach are that it 
may be applied widely for anyone whether or not they are experiencing symptoms 
of anxiety or depression, and that having high levels of well-being is a protective 
factor against developing future mental health problems (Keyes, Dhingra, & 
Simoes, 2010). Although reducing negative symptoms is not the focus of PPIs, 
research shows that individuals have a significant reduction in depressive and 
anxiety symptoms after treatment (Chakhssi, Kraiss, Sommers-Spijkerman, & 
Bohlmeijer, 2018). Both the treatment of mental health problems and the 
enhancement of well-being are essential in the care of people with MS. 
Self-Help Interventions 
Whilst there is a substantial evidence base for psychological interventions, the 
number of available and suitable psychological therapists does not match up to the 
tremendous burden of common mental health problems both in the general 
population and for people with MS. Self-help interventions (SHIs) have the potential 
to fill the shortfall by providing evidence-based therapies with minimal therapist 
contact time. SHIs have primarily been made up of reading material which guides 
the user through psychoeducation and exercises or practices to promote change. 
Traditionally, the material was in printed or book form, and more recently, 
technology has allowed for internet-based and multimedia interactive SHIs. They 
are popular because they can be rolled out to large amounts of people with 
relatively low costs and can be used in a step-cared approach or in addition to 
other interventions on offer.  
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Systematic reviews and meta-analyses have shown SHIs to be effective in 
reducing depression and anxiety symptoms (Cavanagh, Strauss, Forder, & Jones, 
2014; Lewis, Pearce, & Bisson, 2012), medically unexplained symptoms (van Gils 
et al., 2016) and reduce distress in chronic health conditions (Beatty & Lambert, 
2013). The majority of studies of SHIs are for those based on a CBT framework, 
however there is evidence for other models including Acceptance and Commitment 
Therapy (ACT) (Fledderus, Bohlmeijer, Fox, Schreurs, & Spinhoven, 2013), and 
PPIs (Schotanus-Dijkstra, Pieterse, Drossaert, Walburg, & Bohlmeijer, 2017; 
Schueller & Parks, 2012). 
Online SHIs may be particularly relevant for people with MS because they foster a 
sense of autonomy and can be accessed from home, making them accessible for 
those with limited mobility and positively influencing engagement with treatment 
(Rieckmann et al., 2018). However, one could also hypothesise that the effects of 
MS on an individual such as fatigue and cognitive impairment might make 
accessing and engaging with self-help more difficult than compared to other 
populations. Previous reviews that have compared the effectiveness of SHIs 
between populations with different health conditions suggest a significant 
difference in outcomes (Beatty & Lambert, 2013; Matcham et al., 2014), 
emphasising the need for an evidence base in individual conditions. It is therefore 
vital to assess if psychological SHIs are efficacious for people with MS, and if so, 
what components are associated with better outcomes. As far as the authors are 
aware, there are no existing systematic reviews that focus on psychological SHIs 
for people with MS. 
The objective of this review was to determine how effective psychological SHIs are 
for people with MS in reducing distress or improving well-being.  
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Method 
 
A systematic review of the literature was conducted with evidence sourced up to 
the date of the search; 9th December 2018. There was no lower date limit enforced. 
The review process followed the PRISMA guidelines. 
Search Strategy 
Searches of specialist databases were conducted on 9th December 2018 using the 
following index/MeSH (Medical Subject Heading) and strings of keyword terms: 
(Multiple Sclerosis) plus (wellbeing or well-being or "well being" or "quality of life" or 
"positive affect" or "happiness" or “mental health” or anxiety or depression or 
distress or “negative affect”) plus (self-help or "self help" or self-management or 
web-based or "web based" or internet-based or "internet based" or self-directed). 
To increase breadth of results, and to avoid missing studies that used only the 
name of a specific intervention rather than generic terms, no search terms related 
to ‘intervention’ were used. Databases included the Cochrane Database of 
Systematic Reviews, PubMed and PsycINFO. Search results were exported into 
Zotero 5.0.60 software and duplicates removed before titles and abstracts were 
screened in relation to the inclusion/exclusion criteria. The reference lists of all 
primary studies and review articles were searched for additional references. The 
search process is shown in Figure 1. 
Eligibility criteria and study selection. Search results were excluded or included 
based on the following pre-defined inclusion criteria: 
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1. Controlled trials with or without randomisation that reported quantitative 
outcome data following a self-help intervention in people with MS. 
2. Included outcome data on one or more measure of mental health, well-
being or QOL 
3. Participants with an MS diagnosis of any type (e.g. primary progressive, 
secondary progressive, relapsing-remitting, progressive relapsing). 
4. Published in a peer reviewed publication and available in English 
5. Conducted in any country and any setting 
 
To examine the effectiveness of SHIs at improving well-being as broadly as 
possible, no restrictions were placed on the country or setting of the study, MS 
related factors such as type or duration, presence of comorbid conditions, 
symptomatology at baseline, or any individual participant demographic 
characteristics. Studies were excluded if based on purely educational or exercise 
interventions. Searches across all databases yielded n = 165 results. After 
removing duplicates and applying the inclusion/ exclusion criteria to titles and 
abstracts n = 53 remained. Full text articles were retrieved for closer inspection and 
after excluding those that did not fulfil the review eligibility, a final total of seven 
articles were eligible and included in the analysis (see Figure 1). 
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Figure 1. Consort flow diagram of study selection. 
 
Data Extraction Process 
Data required for the critical appraisal and of studies was extracted from the final 
articles by one researcher using a pre-designed data extraction form and entered 
into a summary table to enable easy comparison. The key areas included: aims, 
primary/secondary outcomes, sample, intervention content, length of follow-up, 
analysis methods, results, intervention effectiveness and study limitations.  
Strength of Evidence Assessment of Studies 
The Cochrane Risk of Bias Tool (Higgins et al., 2011) was used to analyse each 
study for bias. The risk of bias tool assesses seven domains which are sequence 
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generation, allocation concealment, blinding of participants and personnel, blinding 
of outcomes assessed, treatment of incomplete data, selective outcome reporting 
and other risks of bias. The risk of bias in each subcategory was classified as high, 
low or unclear. The assessment of bias was conducted by the author (EB) and 
borderline decisions were discussed with their supervisor (AM) to achieve 
consensus. 
Results 
 
Study Characteristics 
Seven RCTs were included in the review (see Table 1). One study was designed to 
increase levels of physical exercise and was included after discussion due to the 
intervention being based on psychological theory, involving psychological 
components, and having psychological outcomes. Of the seven studies, all seven 
evaluated the impact of the intervention on depression, five on anxiety, four on 
QOL, and one on Well-being as an outcome. Psychological variables were the 
primary outcome measure for three studies, and a secondary outcome measure in 
four studies in which the primary outcome measure was Fatigue (n=3) and physical 
activity (n=1). Sample sizes varied from 11 to 275, the total and mean numbers of 
participants were 673 and 96, respectively. The participants' mean ages from the 
studies ranged between 41- 51 years, with all but one study having a mean age in 
the 40s. Between 74% and 91% of each sample was female. 
Six of the seven studies based their intervention on CBT principles, and one based 
their behavioural intervention on social cognitive theory. The components of the 
intervention varied, with three including comprehensive elements of CBT such as 
psychoeducation, emotions, cognitive restructuring, behavioural activation, self-
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monitoring. One of these studies, in addition, included positive psychology 
strategies to increase well-being. One study focussed mainly on psychoeducation 
and cognitive restructuring. The intervention in all seven studies was delivered 
online for participants to access at home. The level of guidance offered during the 
SHI varied. In three studies, participants received no guidance (pure self-help); in 
two, weekly email support; in one, up to three telephone support sessions; and 
one, weekly – monthly Skype support.  
Duration of the intervention period ranged between six and twelve weeks for six of 
the studies, and six months for one study. The total time participants were 
expected to spend accessing the intervention was specified in four studies and 
ranged between 4-10 hours; approximately 30 – 60 minutes per week. Six studies 
used a waitlist control, and one used an active control. Three studies included a 
long-term follow-up at either three, four, or six months post-intervention. 
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Table 1  
Information for the final studies included in the current review 
First Author 
(year) 
Sample 
Characteristics 
Intervention Format 
and Components Study Design 
Outcomes and 
Measures Summary of Findings 
Strengths and 
Limitations 
Drop-out 
Rate 
Boeschoten 
et al., 
(2017) 
N = 171 
Mean Age: 48.9  
(SD = 10.5) 
80% Female 
Depressed 
(Moderate and 
severe) 
45% able to walk 
without aid or rest 
for 500m  
Name: “Minder Zorgen” 
(“Worry Less”) 
Duration: 5 modules; 5 
hours over 5 – 10 
weeks 
Delivery: Online with 
weekly email support 
Components: PST, 
CBT  
RCT 
Control 
Condition: 
WLC 
Follow-up: 4 
months 
Primary: 
Depression; BDI-
II 
Secondary: 
Anxiety; HADS-
A; BAI, Fatigue; 
FSS, Cognitive 
Symptoms; 
MSNQ, Impact of 
MS; MSIS-29, 
HR-QOL; EQ-5D 
Problem-solving; 
SPSI-R, 
Mastery; PMS  
No treatment effect relative to controls on 
any measure using an ITT analysis: BDI-
II: (p=.26, d=.23), HADS-A: (p=.46, 
d=.11), BAI: (p=.10, d=.20), FSS: (p=.33, 
d=.17), MSNQ: (p=.54, d=.06), MSIS-29: 
(p=.72, d=.03), EQ-5D: (p=.35, d=.13), 
SPSI negative: (p=.26, d=.14), SPSI 
positive: (p=.44, d=.10), SPSI avoidant: 
(p=.17, d=.16), PMS: (p=.50, d=.09) 
Significant within-group reduction in 
depression (d=1.18), maintained at follow-
up (d = 1.11). Control group also had 
unexpected significant improvements in 
depression pre-post (d = 0.95) and at 
follow-up (d = 1.12). 
- Self-report 
outcomes 
-Low 
adherence 
rates (67% 
completers) 
11% at T1, 
23% at T2. 
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First Author 
(year) 
Sample 
Characteristics 
Intervention Format 
and Components Study Design 
Outcomes and 
Measures Summary of Findings 
Strengths and 
Limitations 
Drop-out 
Rate 
Fischer et 
al., (2015) 
N = 90 
Mean Age: 45.28 
(SD=11.6) 
78% Female 
Depressed 
50% Able to walk 
without aid or rest 
for 500m 
(Measured by 
HAQUAMS item 
15) 
Name: “Deprexis” 
Duration: 10 Modules; 
10 hours over 9 weeks 
Delivery: Online and 
automated; pure self-
help 
Components: PsyEd, 
BA, CM, MF, Acc, IPS, 
Rel, PhysEx, LSMod, 
PS, expressive writing 
and forgiveness, PP, 
EFI 
RCT 
Control 
Condition: 
WLC 
Follow-up: 6 
months 
Primary: 
Depression; BDI 
Secondary: 
QOL; WHO-QoL 
BREF 
HR-QOL; 
HAQUAMS 
Fatigue; FSMC 
Significant treatment effect relative to 
controls for depression (p=0·015, 
d=0·53), Psychological well-being 
subscale of WHO-QOL-BREF (p=0·04, 
d=0·44), and motor fatigue subscale of 
FSMC (p=0·03, d=0·46). 
Mean depression scores at follow-up 
were significantly lower than at baseline 
for the intervention group (p=0.001); 
statistics relative to controls are not 
reported. No information regarding 
secondary outcomes at follow-up is 
reported.  
-Excluded 
suicidal 
ideation 
-Self-report 
outcomes 
- Lack of 
reporting of 
statistics from 
follow-up 
21% 
Moss-Morris 
et al., 
(2012) 
N = 40 
Mean Age: 41.0 
(SD=14.6) 
Name: “MS Invigor8” 
Duration: 8 Modules; 4-
8 hours over 8-10 
weeks 
RCT Primary: Fatigue 
Severity; Fatigue 
Scale 
Significant treatment effect relative to 
controls on all measures: Fatigue severity 
(p<.001, d=1.19), fatigue impact (p<.001 
d =1.22), Anxiety (p=.001), Depression 
(p=.001), and HR-QOL (p= .038). 
-Low 
adherence 
(60.8% 
completed half) 
13% 
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First Author 
(year) 
Sample 
Characteristics 
Intervention Format 
and Components Study Design 
Outcomes and 
Measures Summary of Findings 
Strengths and 
Limitations 
Drop-out 
Rate 
81.6% Female 
Significant Fatigue 
All Participants 
were ambulatory 
with or without a 
stick for at least 
100 meters 
Delivery: Online; up to 
3 telephone support 
sessions (30-50mins 
each); automated 
emails 
Components: CBT, 
PsyEd, self-monitoring, 
CM, BA, EFI, LSMod 
Control 
Condition: 
WLC 
No follow-up 
Fatigue Impact; 
MFIS 
Secondary: 
Depression; 
HADS-D  
Anxiety; HADS-A 
QOL; EQ-5D 
-No Follow-up 
-Bugs in 
software 
Motl et al., 
(2017) 
N= 47 
Mean Age: 51.9 
(SD = 8.6) 
76% Female 
Low activity levels 
EDSS: median 
IQR = 3.5 (2.0); 
Name: No name given 
Duration: 4 modules 
over 6 months. 
Expected hours not 
reported. 
Delivery: Online 
multimedia website and 
interactive video 
RCT 
Control 
Condition: 
WLC 
No follow-up 
Primary: 
Physical Activity; 
GLTEQ and 
accelerometer 
data 
Secondary: 
Fatigue Severity; 
FSS 
Significant treatment effect relative to 
controls for physical activity on GLTEQ (P 
= 0.05, ηp2 = 0.10), overall fatigue impact 
on MFIS (P = 0.018, ηp2 = 0.13), and the 
Physical subscale of MFIS (P = 0.003, ηp2 
= 0.2), disability on MSWS-12 (P = 0.047, 
ηp2 = 0.1) and EDSS (P = 0.03, ηp2 = 
0.11). 
No significant difference relative to 
controls on moderate exercise measured 
-excluded ages 
>63 
- many 
excluded at 
screening 
-very good 
adherence 
(93%) 
0% 
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First Author 
(year) 
Sample 
Characteristics 
Intervention Format 
and Components Study Design 
Outcomes and 
Measures Summary of Findings 
Strengths and 
Limitations 
Drop-out 
Rate 
Most participants 
were able to walk 
without aid or rest 
for at least 500m 
courses, with weekly – 
monthly Skype support. 
Components: Social 
Cognitive Theory, self-
efficacy, outcome 
expectations, 
impediments, goal-
setting, self-monitoring 
Fatigue Impact; 
MFIS 
Pain; SF-MPQ 
Disability; EDSS; 
PDDS; MSWS 
Depression; 
HADS-D 
Anxiety; HADS-A 
by accelerometer (P = 0.24, ηp2 = 0.04), 
fatigue severity (P = 0.10, ηp2 = 0.06), 
Cognitive subscale of MFIS (P = 0.2, ηp2 
= 0.04), Psychosocial subscale of MFIS 
(P = 027, ηp2 = 0.03), or Pain (P= .70, ηp2 
= .00). 
No significant difference relative to 
controls for disability on PDSS (P = 0.1, 
ηp2 = 0.07), Depression (P = .10, ηp2 = 
.07), or Anxiety (P = .06, ηp2 = .09). 
- very low 
attrition 
Pöttgen et 
al., (2018) 
N=275 
Mean Age: 41.4 
(SD; 11.4) 
80.5% Female 
Reporting Fatigue 
Name: “ELEVIDA”  
Duration: Twice a week 
Over 12 weeks (mean 
time of modules not 
specified) 
RCT 
Control 
Condition: 
WLC 
Follow-up: 3 
months 
Primary: Fatigue; 
CFS 
Secondary: 
Motor and 
Cognitive 
Fatigue; FSMC 
Significant treatment effect relative to 
controls for Fatigue on CFS (p=0.0007, 
d=0.53), FSMC-cognition (p=0.009), 
FSMC-motor (p=0.006) and Fatigue QOL 
(p=0.0001); for anxiety (p=0.04), thinking 
QOL (p=0.045), lower mobility QOL 
- 11% 
participants 
never 
accessed 
programme. - 
Large variation 
in adherence 
19% at T1 
and 21% at 
T2 
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First Author 
(year) 
Sample 
Characteristics 
Intervention Format 
and Components Study Design 
Outcomes and 
Measures Summary of Findings 
Strengths and 
Limitations 
Drop-out 
Rate 
PDSS: 64% able 
to walk without aid 
or rest for at least 
500m 
Delivery: Online, pure 
self-help with Optional 
text reminders 
Components: CBT 
using ‘simulated 
Dialogue’, 
Psych-Ed, Mindfulness, 
acceptance, CM, 
imagery, self-
monitoring, improving 
sleep, BA, social 
support 
Anxiety; HADS-A 
Depression; 
HADS-D 
HR-QOL; 
HAQUAMS 
Cognitive 
Symptoms; 
MSNQ 
Impact on daily 
Living; FAI 
(p=0.039), and impact on daily living 
(p=0.005). 
Treatment effects relative to controls 
maintained at follow-up for Fatigue on 
CFS (p=0.008), FSMC-cognition 
(p=0.004), FSMC-motor (p=0.02) and 
Fatigue QOL (p=0.01); thinking QOL 
(p=0.049), and impact on daily living 
(p=0.02); but not for Anxiety (p=0.052), or 
lower mobility QOL (p=0.38). 
No treatment effect relative to controls for 
depression (p=0.196), cognitive 
symptoms (p=0.089), upper mobility QOL 
(p=0.22), mood QOL (p=0.184), or 
communication QOL (p=0.107). 
-Effect sizes 
not reported for 
secondary 
outcomes or at 
Follow-up 
- Large sample 
size 
- Numerous 
sensitivity 
analyses 
conducted to 
confirm 
treatment 
effects 
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First Author 
(year) 
Sample 
Characteristics 
Intervention Format 
and Components Study Design 
Outcomes and 
Measures Summary of Findings 
Strengths and 
Limitations 
Drop-out 
Rate 
Tietjen et 
al., (2018) 
N=11 
Mean Age: 45.0 
(10.0) 
90.9% Female 
Depressed 
(Moderate - 
Severe) 
Name: ‘‘Think Clearly 
About Depression’’ 
Duration: 8 weeks 
(time duration not 
specified) 
Delivery: Online, pure 
self-help 
Components: PsyEd, 
CM, EFI, hopeful 
thinking 
Secondary 
analyses of a 
pilot RCT, 
using sub-
sample of 
people with 
MS 
Control 
Condition: 
WLC 
No long-term 
follow-up 
Primary: 
Depression; 
PHQ-8 
Secondary: 
Health-related 
Emotional 
distress; HDS 
Self-perceived 
health status; 
SRHS 
Self-efficacy; 
CDSES 
Only descriptive statistics reported due to 
small sample. 
Clinically significant improvement in 
depression for 60% of the treatment 
group (0% in control). 
Trends in improvements for health 
distress, and self-efficacy in relation to 
managing disease, doing chores, social 
activities, managing symptoms, and 
managing depression. 
-Small MS 
sample 
-descriptive 
statistics only 
-No Follow-up 
-Self-report 
13% (of 
whole 
sample, not 
reported for 
MS sub-
sample 
specifically) 
Van Kessel 
et al., 
(2016) 
N= 39 
Mean Age:  
45 (SD=8.1) 
Name: “MS Invigor8-
Plus”  
RCT 
Control 
Condition: 
Active control 
Primary: Fatigue 
severity; CFSM;  
Significant treatment effect relative to 
controls for Fatigue on CFSM (p < 0.01, d 
= 0.99) and FIS (p < 0.02, d= 0.81). 
-Small sample 
-Outcome 
measures 
completed 
21% for 
Plus Group 
55% for 
Controls 
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First Author 
(year) 
Sample 
Characteristics 
Intervention Format 
and Components Study Design 
Outcomes and 
Measures Summary of Findings 
Strengths and 
Limitations 
Drop-out 
Rate 
74% Female 
Estimated EDSS: 
46.5% able to 
walk without aid or 
rest for at least 
500m 
Duration: 8 Modules; 4-
8 hours over 8-10 
weeks 
Delivery: Online, with 
weekly email support 
(10mins per week) 
Components: CBT, 
PsyEd, self-monitoring, 
CM, BA, EFI, LSMod 
of 
MSInvigor8-
Only, with no 
support 
No follow-up 
Fatigue Impact; 
FIS 
Secondary: 
Anxiety; HADS-A 
Depression; 
HADS-D 
No significant treatment effect relative to 
controls for Anxiety (p = 0.83) or 
Depression (p = 0.21). 
Effect sizes for within-group effects: 
Fatigue Severity; MSInvigor8-Plus Pre-
Post (d=1.35); MSInvigor8-Only Pre-Post 
(d=0.54)  
Fatigue Impact: MSInvigor8-Plus Pre-
Post (d=1.08); MSInvigor8-Only Pre-Post 
(d=0.54)  
when most 
Participants 
had not 
completed the 
modules. 
-No long-term 
Follow-up 
Outcomes Key: BAI = Beck Anxiety Inventory; CDSES = Chronic Disease Self-Efficacy Scales; CFS = Chalder Fatigue Scale; EQ5D = EuroQol quality of 
life measure; FSMC = Fatigue Scale For Motor And Cognitive Function; FIS = Fatigue Impact Scale; FSS = Fatigue Severity Scale; GLTEQ = Godin 
leisure time exercise questionnaire; HADS = Hospital Anxiety and Depression Scale; HAQUAMS = Hamburg Quality of Life Questionnaire in Multiple 
Sclerosis; HDS = Health Distress Scale; MSNQ = Multiple Sclerosis Neuropsychological Questionnaire; SRHS = Self-Rated Health Scale; MSIS = Multiple 
Sclerosis Impact Scale; PHQ-8 = Personal Health Questionnaire Depression Scale (Risk question excluded); PMS = Pearlin Mastery Scale; SPSI-R = 
Social Problem Solving Inventory-Revised; WHO-QoL BREF = WHO Quality of Life scale 
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Intervention Components Key: Acc = Acceptance; BA = Behavioural Activation; CM = Cognitive Modification; EFI = emotion-focus interventions; IPS = 
interpersonal skills; LSMod = lifestyle modification; MF = Mindfulness; PhysEx = physical exercise; PP = Positive Psychology; PS = problem solving; 
PsyEd = psychoeducation; Re = relaxation   
36 
 
Risk of Bias 
Studies were assessed for risk of bias using the Cochrane collaboration 
assessment tool, illustrated in Table 2. Six of the seven papers reported an 
adequate method of sequence generation and six reported adequate concealment 
of intervention allocation. None had blinding of participants and study personnel. All 
seven reported blind outcome assessment; six collected online, and one used 
assessors blind to group. Five studies reported sufficient information to indicate an 
adequate assessment of incomplete outcome data, and five indicated a lack of bias 
due to selective outcome reporting. The overall assessment of the risk of bias was 
low (n=5), low-moderate (n=1) and high (N=1). 
  
37 
 
Table 2  
Cochrane risk of bias tool assessment for included studies 
  
First Author 
and year of 
study 
Random 
sequence 
generation 
Allocation 
concealment 
  Blinding of 
participants 
and 
personnel 
Blinding of 
outcome 
assessment 
Missing data 
addressed 
Selective 
outcome 
reporting 
Other 
bias Decision 
Boeschoten et 
al., (2017) 
LOW LOW HIGH LOW LOW LOW MODERATE LOW 
Fischer et al., 
(2015) 
LOW LOW HIGH LOW LOW MODERATE LOW LOW 
Moss-Morris 
et al., (2012) 
LOW LOW HIGH LOW LOW LOW MODERATE LOW 
Motl et al., 
(2017) 
LOW UNCLEAR HIGH LOW UNCLEAR LOW MODERATE MODERATE 
Pöttgen et al., 
(2018) 
LOW LOW HIGH LOW LOW LOW MODERATE LOW 
Tietjen et al., 
(2018) 
LOW UNCLEAR HIGH LOW HIGH HIGH UNCLEAR HIGH 
Van Kessel et 
al., (2016) 
LOW LOW HIGH LOW LOW LOW MODERATE LOW 
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Well-being 
Only one study attempted to measure psychological well-being as an outcome 
variable in addition to health-related QOL (HR-QOL), using the Psychological well-
being subscale of the WHO-QOL-BREF. Fischer and colleagues (2015) saw 
significant improvement compared to controls in the Psychological well-being 
subscale only of the WHO-QOL with a small to medium effect size. The 
intervention (“Deprexis”) that focusses on depression is also the only intervention 
that included PPI strategies. 
Anxiety 
Five studies examined the impact of an SHI on anxiety outcomes. All used the 
Hospital Anxiety and Depression Scale (HADS) as the outcome measure, and one 
additionally used the Beck Anxiety Inventory (BAI). The HADS Anxiety subscale 
(HADS-A) includes seven items that measure the frequency of anxiety symptoms 
in the past week. The possible range of scores is 0-21, higher scores indicate more 
frequent symptoms of anxiety (<8 subclinical; 8-10 mild; 11-14 moderate; 15-21 
severe). Baseline HADS-A scores for intervention groups ranged between 5.2 and 
10.4, indicating mostly subclinical to mild anxiety. Four studies used a wait-list 
control, and one used an active control (MSInvigor8-Only vs MSInvigor8-Plus) for 
comparison. Two had a long-term follow-up. 
All five interventions saw a reduction in scores on the HADS-A pre-post. Four 
reported that the intervention group means at all time points and reduction ranged 
from -1.1 to -1.8 points. This reduction was significant compared to the control 
group in only two of the studies (Moss-Morris et al., 2012; Pöttgen et al., 2018). 
Both interventions, ‘MSInvigor8’ and ‘ELEVIDA’, are designed to reduce the 
severity and impact of fatigue and only included participants with high reported 
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fatigue. ‘MSInvigor8’ saw the most substantial significant mean reduction of -1.8 
points on the HADS-A pre-post compared to the waitlist control group who had an 
increase of 2.1 points. Pöttgen and colleagues (2018) did not report mean group 
scores but saw a significant mean difference between intervention and waitlist 
control groups pre-post of -0.64. The mean difference was maintained at three 
months follow-up but was no longer significant. 
Interestingly the study by Van Kessel and colleagues (2016) of MSInvigor8-Plus, 
which is the MSInvigor8 intervention with weekly email support from a clinical 
psychologist instead of telephone support, did not find a significant reduction in 
anxiety compared to their active control group (Invigorate-Only, no telephone or 
email support). The Invigor8-Plus group saw a -1.1 reduction pre-post compared to 
Invigor8-Only who saw a mean reduction of –0.86. The results suggest that some 
therapist support may be an important component of this intervention for anxiety, 
and telephone support results in more beneficial results than email support. This 
study had a higher dropout rate than Moss-Morris and colleagues’ study which may 
also account for some of the difference in results because an intention to treat 
analysis was used (13% vs 38%). 
The Boeschoten and colleagues (2017) intervention study had the highest baseline 
Anxiety scores (HADS-A = 10.4), but despite the intervention group achieving a -
1.4 change in anxiety levels post-intervention that was maintained at follow-up (-
1.6), they did not see a significant mean difference compared to the waitlist control 
who had similar and unexpected reductions in anxiety. The behavioural 
intervention (Motl et al., 2017) also saw a trend towards a significant reduction of -
1.4 pre-post, which equated to a mean difference of -1.3 compared to controls, with 
a medium to large effect size; however, this was non-significant. The mean 
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difference in this study compares favourably to that of ELEVIDA that did achieve 
significance, and this may be due to the difference in sample size and therefore, 
power (n = 47 vs n=275). Unfortunately, Pöttgen and colleagues did not report 
effect sizes for their secondary outcomes for comparison.  
Depression 
All seven studies examined the impact of a SHI on depression outcomes. Four 
studies used the depression subscale of the HADS (HADS-D) as an outcome 
measure, two studies used the BDI-2, and one used the PHQ8. HADS-D scoring is 
identical to the HADS-A, described previously. The BDI-2 ranges from 0-63: 0-13 
subclinical; 14-19 = Mild; 20-28=Mod; 29 = < = Severe. The PHQ8 scores range 
from 0-24: 5-9 = Mild, 10-14 = Moderate, 15-19 Moderately Severe, and 20+ = 
Severe. Baseline mean depression scores were in the subclinical-mild range in the 
four studies for which depression was not a primary outcome, and Mild-Moderate 
(n = 1) or Moderate-Severe (n = 2) in the studies for which depression was the 
primary outcome. 
A significant treatment effect, relative to controls, was found in two studies (Fischer 
et al., 2015; Moss-Morris et al., 2012). Baseline mean depression scores in Moss-
Morris and colleagues’ study (2012) were within the subclinical to mild range 
(HADS-D = 7.96 SD = 3.64), and they found a significant mean difference between 
groups pre-post of -4.76 on HADS-D. Effect size was not reported. In Fischer and 
colleagues (2015) study, mean baseline depression was in the mild to moderate 
range (BDI-2 = 19.44, SD = 9.02), and they found a significant mean difference 
between groups pre-post of -4.02 on BDI-2 with a medium effect size, maintained 
at six months follow-up. 
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The Boeschoten and colleagues (2017) study included participants with moderate 
to severe depression at baseline and found a significant within-group reduction in 
depression score of -7.9 on BDI-2 pre-post with a large effect size, which was 
maintained at four months follow-up. However, this was not significantly different to 
the control group who also had unexpected improvements in depression pre-post 
and at follow-up. Tietjen and colleagues (2018), looking at an MS-only subsample 
of a larger trial of the ‘Think Clearly About Depression’ intervention, also designed 
to treat depression, found a mean difference between groups of -8.43 pre-post on 
the PHQ8, however due to a small sample size (n = 11) they did not report 
significance statistics (Tietjen, Wilson, Amiri, & Dietz, 2018). Motl and colleagues’ 
(2017) study of a Behavioural Intervention which found a significant increase in the 
primary outcome of physical activity saw a mean difference between groups pre-
post of -1.3 on HADS-D, which although had a medium effect size, was non-
significant. Pöttgen and colleagues (2018), in their intervention for fatigue, saw no 
significant difference between groups on HADS-D pre-post or at three months 
follow-up despite seeing a significant reduction in the primary outcome, and to a 
lesser extent, anxiety. MSInvigor8-Plus, in a sample reporting subclinical to mild 
levels of baseline depression, saw a mean difference between groups of -1.32 on 
HADS-D pre-post that was non-significant. 
Quality of Life 
Only one study (Fischer et al., 2015) included a QOL measure, the WHO-QOl-
BREF, as opposed to a HR-QOL measure. HR-QOL focuses on an individual’s 
symptoms and impairments, and how the effects of illness and treatment impact on 
QOL. The WHO-QOL-BREF covers four domains of Physical, Psychological, 
Social Relationships and Environment, and scores are converted into a percentile 
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score (0 -100). Four of the seven studies included a measure of HR-QOL, either 
the EQ-5D (n = 2) or the HAQUAMS (n = 2). The EQ-5D includes five items, 
covering five domains: mobility, self-care, usual activities, pain/discomfort and 
depression/anxiety. Individuals get an index score between 0 and 1, with higher 
indicating better perceived functioning. In line with previous research, baseline EQ-
5D scores for MS samples in this review were lower than population norms for the 
perspective country and age group (0.47 vs. 0.87 in Netherlands; 0.56 vs. 0.90 in 
the UK). The HAQUAMS is a MS-specific HR-QOL measure and covers the six 
domains of Fatigue, thinking, mobility in upper extremities, mobility in lower 
extremities, mood and communication. 
Three of the four studies saw a significant increase in QOL or HR-QOL on at least 
one subscale pre-post, relative to controls. Effect size was only reported for one 
study and it was small to medium; The Fischer and colleagues (2015) study saw a 
significant improvement relative to controls in the Psychological well-being 
subscale only of the WHO-QOL but saw no difference in the HAQUAMS subscales.  
The Moss-Morris and colleagues’ study, focussing on fatigue, found a significant 
improvement in HRQOL on the EQ5D compared to controls of 0.15. Pöttgen and 
colleagues (2018) found HR-QOL was significantly increased relative to controls for 
the fatigue, thinking and mobility lower extremities subscales of the HAQUAMS. 
The improvement was maintained at 3-month follow-up for fatigue and thinking 
subscales. 
Discussion 
 
To the author’s knowledge, this is the first review that has specifically focused on 
examining the effectiveness of SHIs at reducing distress and improving well-being 
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in people with MS. This review highlights the paucity of high-quality controlled trials 
available and identifies a significant gap in the research literature. The paucity of 
studies in this area is in line with a 2014 systematic review and meta-analysis of 
written SHIs for people with a physical health condition, in which none of the 29 
RCTs identified was with an MS population (Matcham et al., 2014). All seven of the 
studies identified in this review apart from one were published after 2014, which 
hopefully indicates a recent trend towards an increased interest in the area.  
Treatment Effects 
Most studies (n = 5) achieved a significant result in their primary outcome 
compared to controls, suggesting that self-help formats may be suitable for people 
with MS. Effect sizes in relation to control group in primary outcome were reported 
in four studies and varied between medium (d = 0.53) and large (d = 1.22). The 
effect sizes are comparable to those of meta-analyses of SHIs in other populations 
that generally find a medium effect size (Farrand & Woodford, 2013), or a large 
effect size for computerised CBT for depression or anxiety (ES = 0.88, NNT 2.15) 
(Andrews, Cuijpers, Craske, McEvoy, & Titov, 2010), suggesting that some SHIs 
can be just as effective for people with MS. Of the four studies that reported effect 
size at post-treatment, two had a long term follow and although treatment gains 
were still significant, neither reported effect size at this time, so it is unclear to what 
extent treatment gains are maintained. 
Fatigue. SHIs based on a CBT framework aimed at reducing fatigue were 
successful in all four studies with moderate to large effect size, suggesting that 
SHIs of this kind can be efficacious in people with MS. Participants also saw an 
improvement in HR-QOL in the two studies that measured it, which is in line with 
literature that shows MS-related fatigue significantly impacts HR-QOL (Bol, Duits, 
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Hupperts, Vlaeyen, & Verhey, 2009). Fatigue is identified by people with MS as 
one of the most common and troubling problems and the results from this review 
suggest that SHIs targeting fatigue may be a promising treatment to help alleviate 
the severity and impact on QOL. Indeed, if as many as 92% of people with MS 
complain of fatigue (Brañas, Jordan, Fry-Smith, Burls, & Hyde, 2000), and in the 
absence of any reported negative consequences from fatigue SHIs, then an SHI 
could justifiably be offered to all those diagnosed. The relatively low baseline levels 
of depression in this sample of people with MS with high fatigue is surprising 
considering the strong positive association between fatigue and depression in 
people with MS (Bol et al., 2009). 
Another surprising finding considering this association, is that of the four successful 
Fatigue SHIs, only one saw significant reduction in depression (MSInvigor8 with 
telephone support; Moss-Morris et al., 2012). Quality of sleep is one variable that 
has been shown to account for a high variance in the relationship that exists 
between MS fatigue and depression (Strober & Arnett, 2005); MS symptoms cause 
disturbed sleep resulting in both fatigue and low mood, and disturbed sleep as a 
symptom of depression causes fatigue. Both MSInvogr8 and ELEVIDA contain an 
‘Improving Sleep’ module but ELEVIDA did not see an improvement in depression 
symptoms, perhaps due to the low baseline levels already mentioned. Another 
pathway that MSInvigor8 could improve depression and anxiety symptoms is 
through teaching coping strategies which could be generalised, as coping style 
(e.g. avoidant versus active) is consistently associated with depression and anxiety 
(Arnett, Barwick, & Beeney, 2008; Feinstein, Magalhaes, Richard, Audet, & Moore, 
2014). The one study that had physical activity as a primary outcome saw 
significantly increased physical activity and improved motor fatigue, providing 
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further evidence that people with MS can utilise SHIs to make significant 
behavioural changes.  
Depression. For the two studies that found significant treatment effects on 
depression relative to controls, only one reported an effect size and had a follow-up 
(Fischer et al., 2015). The effect size for pre-post was medium to large, and 
although depression was significantly lower at follow-up compared to baseline, 
results are not reported relative to controls, and nor was an effect size. Fischer and 
colleagues (2015) study assessing ‘Deprexis’ was of high quality and at a low risk 
of bias, making their findings worthy of future research. ‘Deprexis’ is fully 
automated requiring no clinician contact and achieved significant results despite a 
moderate sample size (n = 90) and 21% attrition. The results are in line with 
previous literature that has identified depression SHIs in particular to be efficacious 
in a pure-self-help format.  
The other study that focussed on depression (Boeschoten, Dekker, et al., 2017), 
saw a surprising significant improvement in the WLC group as well as the 
intervention group, which resulted in a non-significant difference between the 
groups. The results of this review suggest that depression can be improved using 
SHIs in people with MS, but it may need to be targeted directly; participants who 
had significantly reduced fatigue or increased physical activity did not necessarily 
experience a reduction in depression or anxiety symptoms. Baseline mean levels 
of anxiety and depression in these studies were all in the subclinical to mild range 
and so a ceiling effect may have occurred where participants did not have much 
room to improve. 
Quality of Life. Three of the four studies included in this review that used a QOL 
or HR-QOL outcome measure saw an improvement on at least one subscale, 
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suggesting that improvements in depression and fatigue from SHIs can be 
translated into an improved quality of life for people with MS. However, effect size 
was only reported for one study, which was small to medium.  
Only one study included a QOL measure, with most choosing to use a health-
related QOL measure only. HR-QOL measures have been criticised for having an 
exclusive focus on symptomology, with little emphasis on positive aspects of QOL. 
This limits the understanding they provide, as research shows that treating 
depression in people with MS influences both the negative and positive aspects of 
QOL (Hart, Fonareva, Merluzzi, & Mohr, 2005).  
The ‘Deprexis’ study (Fischer et al., 2015), that saw a significant improvement in 
their primary outcome of depression and secondary outcome of Motor Fatigue, 
found a significant improvement in the psychological well-being subscale of the 
WHOQOL-BREF (ES =0.44). This intervention was the only one included in the 
review which utilised PPI modules that included strategies such as expressive 
writing and forgiveness, suggesting that SHIs could be used to increase the well-
being of people with MS. This may be an important and clearly under-researched 
area in MS. 
Interestingly, the changes observed did not translate to an improvement in HR-
QOL as measured by the HAQUAMS, including the Mood subscale (ES=0.00). 
This finding is in line with research suggesting that psychological well-being is a 
separate construct to HR-QOL. Unlike a lot of HR-QOL measures, the HAQUAMS 
does include four positive items within the Mood domain regarding contentment, 
enjoyment, sense of purpose and energy. However, for the people with MS in this 
particular sample, the questions captured something different to the psychological 
well-being domain in WHO-QOL-BREF, which includes six questions related to 
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bodily image, negative feelings, positive feelings, self-esteem, spirituality, thinking, 
learning and concentration. The results of this study seem at odds with the findings 
that depression is a strong predicter of reduced HR-QOL, which would suggest an 
improvement in depression would result in an improvement in HR-QOL. These 
findings underscore the importance of examining well-being with two or more 
complementary approaches.  
 
Intervention characteristics 
Only three of the interventions were designed to target mental health specifically, 
and these all focussed on depression. No studies meeting the review criteria were 
identified that assessed an intervention targeting any type of anxiety, nor any 
designed specifically to improve well-being in the form of a Positive Psychology 
Intervention (PPI). The lack of an anxiety focus is surprising considering that a third 
of people with MS will be diagnosed with an anxiety disorder (Marrie et al., 2013), 
and that many SHIs exist for anxiety disorders in the general population which 
have been shown to be efficacious with a large effect size (Lewis et al., 2012). In 
terms of neuropsychiatric symptoms, fatigue received the most interest (n = 3) 
whilst no studies used an intervention targeting cognitive impairment. This may be 
due to the medical profession only relatively recently acknowledging the strong 
impact cognitive impairment has on QOL (Mitchell et al., 2005), and a lack of high 
quality studies showing efficacy for cognitive rehabilitation (Chiaravalloti & DeLuca, 
2008). 
All seven of the studies included in this review used an internet-based delivery 
method. This may reflect a trend towards computer-based programs for self-help 
as opposed to traditional written material or audio. In a 2010 meta-analysis of 
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studies comparing guided SHIs to face-to-face therapy, only seven of the 24 
guided SHI conditions used a computer based delivery method (Cuijpers, Donker, 
Straten, Li, & Andersson, 2010). The majority of SHIs were based on a CBT 
framework, with one also incorporating PPI modules, and one was a behavioural 
intervention. Therapeutic frameworks which have an evidence base in the general 
population and in physical health such as ACT and PPI appear to be 
underrepresented in research in people with MS. A recent systematic review of 
ACT interventions in long-term conditions, which have considerable evidence base 
in the domain of physical health, found only two studies with people with MS 
(Graham, Gouick, Krahé, & Gillanders, 2016), and none were in a self-help format. 
There was significant homogeneity in terms of the theoretical framework the 
interventions were based on, with six out of seven using CBT. Despite this, there 
was heterogeneity in terms of the intervention content, as well as baseline 
symptomology and amount of therapist guidance between in the interventions. Due 
to the small amount of studies, and the varied amount of information regarding 
intervention content available, it is not possible to ascertain which factors 
determine the effectiveness of a self-help programme for people with MS. Previous 
literature suggest that the most effective interventions tend to be based on a 
therapeutic model and involve relaxation therapy, goal setting and cognitive 
restructuring (Matcham et al., 2014), which applies to most of the included 
interventions.  
Although there have been studies concluding that increased support or guidance 
results in better outcomes in SHIs, this notion has been challenged recently by 
several meta-analyses. For example, a meta-analyses that only included studies at 
low risk of bias, found no significant difference in outcome between pure-self-help, 
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minimal contact, or guided SFIs (Farrand & Woodford, 2013); another found no 
significant difference in outcome between face-to-face CBT and computerised CBT 
(Andrews et al., 2010); and another found no significant difference between pure 
SHIs and those with minimal therapist contact (Hirai & Clum, 2006).  
There are not enough studies available in this current review to ascertain what 
level of guidance is optimal for people with MS, which may differ to that of other 
populations. There does however appear to be a trend towards improved outcomes 
with increased guidance. For example, the MSInvigor8 intervention saw the largest 
effect size when delivered face-to-face; effect sizes reduced slightly in an SHI 
format when accompanied by telephone support, reduced further with email 
support, and were smallest with no support (Moss-Morris et al., 2012; van Kessel, 
Wouldes, & Moss-Morris, 2016). Also, within Fischer and colleagues (2015) study, 
they found higher effect sizes in a subgroup of participants that received one face-
to-face assessment appointment in addition to the pure SHI, compared to the 
whole sample. 
Quality of the Studies 
The quality of the studies included in this review was variable, but the majority were 
at a low risk of bias. Only two studies used independent researchers, and five had 
the programme developers themselves evaluating the intervention, which could 
introduce bias.  
Only four studies included in the review clearly used the gold-standard technique of 
intention to treat for all primary analysis. One of the key benefits of an RCT is the 
randomisation of participants into groups, which creates comparable groups whilst 
avoiding selection bias. Changing these groups by removing incomplete data or 
excluding dropouts reduces this comparability (Newell, 1992), and is likely to lead 
50 
 
to biased results. Only three of the studies included in this review explicitly reported 
using a power calculation to ensure the sample would have sufficient power to find 
significant effects.  
Only one study used an active control and the remaining ones used a wait-list 
control. Whilst this is deemed an appropriate control when assessing a novel 
behavioural intervention (Mohr et al., 2009), it is noted that WLC patients may 
decrease their help-seeking behaviours in anticipation of professional help in the 
future, which may lead to an overestimation of intervention effects (Cuijpers et al., 
2010). 
Finally, many studies failed to report effect sizes for secondary outcomes and for 
follow-up outcomes. Failure to report effect sizes compromises comparison of 
treatment effects across studies, and failure to report over periods of follow-up 
limits conclusions that can be reached regarding the efficacy of SHIs. This is 
because inclusion in a study may cause short-term gains that may not be 
maintained, due to motivating participants through the creation of deadlines and 
assessments (Lewis et al., 2012). 
Attrition and Adherence 
Attrition varied between 0 – 55% in intervention groups. Previous research also 
reports large variance in attrition between computerised SHIs in LTCs of 4 – 62% 
(Beatty & Lambert, 2013), with no clear variables identified that directly effecting 
proportions dropping out. In this review there appeared to be a trend in which 
attrition went down as the amount of therapist guidance went up. This was seen in 
the pure SHIs having the largest attrition (n = 3; 19-55%); those that offered email 
support slightly lower (n = 2; 11-23%), and those that provided telephone or Skype 
guidance the least (n = 2; 0-13%), however the number of studies was too small to 
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draw any firm conclusions from this. The high levels of attrition rates in the pure 
self-help studies in this review are similar to those reported by a study of PPI 
strategies in a pure self-help format which had attrition rates of around 50%  
(Schueller & Parks, 2012). The relationship between the amount of therapist 
contact and therapeutic outcome of SHIs is still something that is unclear with 
conflicting results throughout the literature (Beatty & Lambert, 2013). 
Adherence to the intervention varied largely both within and between studies. The 
average amount of participants completing over half of the modules appeared to be 
around 60% in those that reported it, which is lower than median adherence for 
computerised CBT in other populations, which a recent meta-analysis reported is 
80% (Andrews et al., 2010). This may suggest that people with MS find it more 
difficult than other populations to adhere to the full course of a SHI. One included 
study found that the intervention group continued to use the SHI after the predicted 
finishing point and post measures, suggesting that people with MS may need to 
more time allocated to complete the intervention. The exception in this review was 
a behavioural intervention which retained an impressive 100% of participants in the 
intervention group, with an adherence of 97% (Motl et al., 2017). Motl and 
colleagues used Skype guidance which may suggest that more personalised 
guidance helps adherence to the intervention as well as commitment to the study in 
people with MS.  
Although attrition rates varied and the adherence rates seemed to be below that of 
SHIs in other populations, participants in the included studies reported similar high 
satisfaction rates for the SHIs to other populations (Andrews et al., 2010).  
Implications for Practice and Policy 
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Results initially appear encouraging and are in line with existing work that suggests 
SHIs can be effective in reducing distress, and furthermore give evidence for use in 
people with MS explicitly. There is however insufficient evidence to determine the 
exact extent to which SHIs led to improvements in anxiety, depression and QOL in 
people with MS due to the small number of studies available and the variable 
quality observed. 
The self-help approach has received growing recognition in a climate of limited 
resources and pressure on psychological services, and reviews have confirmed 
their potential for effectively treating mental health problems and increasing well-
being. This review highlights that there is a paucity of studies evaluating such 
interventions in individuals with MS. The promising results found in the limited 
amount of high-quality studies supports the ongoing development of SHIs for 
people with MS. A recent systematic review that searched Google and App stores 
in addition to academic online databases for pure online self-help tools (free, 
publicly available, and not requiring a facilitator) for people with MS and depression 
found only two relevant self-management programs (Lukmanji et al., 2017). 
Depression and anxiety did not necessarily improve with improved physical activity 
and fatigue and vice versa. This finding suggests that the primary cause of an 
individual’s distress should be identified and targeted first, and comorbid symptoms 
should be monitored and targeted directly if persisting. 
Directions for Future Research  
The results of this review have highlighted SHIs as a promising area for future 
research for reducing distress and improving well-being in people with MS. 
Ensuring sample sizes are large enough to meet power requirements would 
substantially improve the quality of evidence for future research, although it is 
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noted that this is a relatively new area of research and a specific population making 
large samples challenging to ensure. 
Further research is required to determine the active ingredients of successful 
interventions. There is evidence in the broader literature to suggest that some 
therapist guidance results in better outcomes than pure self-help, however, the 
evidence is unclear and may be different for people with MS, and different target 
domains. Determining the level of guidance at which cost-effectiveness is optimal 
should be an avenue of future research. Furthermore, identifying individual 
predictors of treatment response will be valuable. For example, there may be 
differences between people with low versus high levels of disability, subthreshold 
symptoms versus diagnosed mental health problems, or male versus females. 
Such investigations were not possible in the included studies due to small size and 
homogeneity of the sample demographics, which tended to be majority aged in 
40s, female and with low disability.  
Personal preference of the individual seeking help also needs to be taken into 
consideration; one could hypothesise that those participating in the included trials 
found the concept of an SHI acceptable and were willing to engage, and this is 
unlikely to be the case for all individuals with MS. This variable could be taken into 
account by collecting data from those who decline to participate in future SHI trials.  
Researchers should consider broadening their conceptualization and measurement 
of QOL by using measures that capture both the positive and negative aspects to 
QOL, which may provide useful information in the subsequent development of 
interventions for people with MS.  
Existing SHIs based on therapeutic frameworks others than CBT such as ACT-
based (Brown, Glendenning, Hoon, & John, 2016) or PPI-based approaches, as 
54 
 
well as those designed to improve anxiety, pain and cognitive symptoms should be 
assessed with people with MS to see if they would be of benefit. Any existing SHIs 
should be tailored to people with MS before being trialled to increase potential 
acceptability (Hind et al., 2010). 
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Evaluation of a self-help intervention for improving well-being and reducing 
depression in a sample of people with MS 
 
Abstract 
 
Well-being is an essential aspect of mental health and treatment outcome. ‘GAP’ is 
an intervention that teaches goal-setting and planning skills, and in a self-help 
format has been shown to increase well-being and reduce depression in 
community and depressed samples. People with MS have lowered well-being and 
face challenges concerning adjusting important life goals due to unpredictable 
disease progression and exacerbation. The current study aimed to evaluate the 
effectiveness of GAP in a pure self-help (SHI) format for increasing well-being and 
reducing depression for a sample of people with MS. 
A Randomised controlled trial was employed. 58 participants with MS were 
randomly allocated to receive GAP (n=29) or to wait-list control (n=29). Measures 
of well-being (I-PANAS-SF; Flourishing Scale; FAMS) and depression (PHQ9) 
were taken at baseline, post-intervention, and eight weeks follow-up. A 2 
(treatment vs control) x 3 (Time 1, Time 2, Time 3) repeated measures ANOVA 
was employed to look at differences between the groups.  
The intention to treat (ITT) primary analysis yielded a non-significant result for 
group x time interactions on all outcomes measures. There was a significant 
decrease in depression (F(2,112) = 0.97, p = .005, ηp2 = 0.02) and negative affect 
(F(2,112) = 4.34, p = .018, ηp2= 0.07) for the whole sample over time. A modified 
ITT analysis revealed a significant group x time interaction effect for the Family and 
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Social well-being FAMS subscale only, with a large effect size (F(2, 40) = 4.65, p = 
.012, ηp2 = .12). 
Potential explanations for the results are discussed, including methodological 
issues and MS-related factors resulting in GAP being ineffective. People with MS 
may require therapist guidance due to the increased challenges posed by MS 
requiring more adapting of goals. Further research is needed before 
recommendations could be made to use GAP in a MS population. Directions for 
future research are discussed. 
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Background 
 
Defining Well-being 
Well-being is a multidimensional construct that encompasses various 
psychological, emotional and social dimensions and is an essential aspect of 
mental health and treatment outcome. Definitions of well-being are typically divided 
into either hedonic or eudaimonic approaches. Hedonic approaches equate well-
being with high positive affect, low negative affect, and high life satisfaction; 
eudaimonic approaches equate well-being with the actualisation of human 
experience and potentials, such as relationships or achievements (MacLeod, 
2015). The concept of flourishing combines hedonic and eudaimonic components. 
An individual who is 'flourishing' experiences hedonic well-being, including 
happiness, calmness and peacefulness, but also eudaimonic well-being, through 
engagement with life, positive relationships with others and a sense that life is 
worthwhile (Seligman, 2011). Due to well-being spanning many dimensions, 
measurement usually involves using several measures that cover positive affect, 
negative affect, satisfaction with life, and positive functioning.  
The concept of cultivating well-being, as opposed to treating illness within clinical 
psychology, was popularised by the positive psychology movement (Seligman, 
2002). As discussed in the previous chapter, interventions that aim to bring about 
positive thoughts, feelings or behaviours are known as Positive Psychology 
Interventions (PPIs) and have been found to effective. For example, Sin and 
Lyubomirsky (2009) carried out a meta-analysis of 51 well-being interventions 
which revealed that PPIs significantly enhanced well-being (mean r = 0.29) and 
decreased depressive symptoms (mean r = 0.31). PPIs differ between one another 
in their approach to cultivating well-being and optimal functioning in people. One 
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area that is fundamentally linked to well-being and has been utilised for intervention 
is that of personal goals. 
Goals and well-being 
Goals and related constructs are pervasive in psychological research and span the 
history of psychology. Personal goals are important determinants of quality of life; 
they provide purpose for living, direct individual behaviour, and contribute to long‐
term patterns of successful development. Goals have been defined as internal 
representations of meaningful outcomes that people want to achieve (Austin & 
Vancouver, 1996). 
 
Goals are embedded within the concept of well-being in several ways. An 
individual’s perception of their ability to fulfil goals or aspirations has been 
emphasised as a fundamental component of well-being theories (Felce & Perry, 
1995); Indeed, some theories propose that the definition of well-being itself is to be 
engaged in pursuing goals that have personal value (Schmuck & Sheldon, 2001). 
Extensive research has confirmed the relationship between goals and well-being. 
For example, goal setting and planning skills and working towards intrinsic valued 
goals are associated with high levels of well-being (MacLeod & Conway, 2005; 
Sheldon & Kasser, 2001). The pursuit of chosen goals can increase well-being, the 
type of goals one pursues and even the type of goals one’s partner pursues, 
significantly effect well-being (Headey, Muffels, & Wagner, 2013). In a recent meta-
analysis of 85 studies, the authors found the overall effect of successful goal 
pursuit on well-being yielded a medium to large average effect size of ρ = .43. The 
findings show that goal striving is one of the most important correlates of well-
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being, followed by health (ρ = .32), socioeconomic status (ρ = .20), and personality 
(ρ = .19) (Klug & Maier, 2015). 
 
Similarly, inadequate skills in goal-setting and planning are associated with 
psychological distress. For example, through the pursuit of maladaptive goals or 
too many goals, or through perceived failure to achieve goals. Such events are 
associated with depression, negative affect and can expend an individual’s coping 
resources resulting in perceived stress (Wrosch, Scheier, & Miller, 2013). The 
specific ways in which personal goals can influence well-being will now be explored 
further. 
 
Setting goals: Research has shown that having goals in of itself can increase well-
being by providing structure and meaning to one’s life; Indeed, having goals is a 
potent predictor of life satisfaction (Brunstein, Schultheiss, & Maier, 1999; Emmons 
& Kaiser, 1996). In addition, the goal content and appraisal are influential. The 
relationship between having goals and well-being is strengthened when the goals 
are self-concordant, i.e., where the goals are those that people either enjoy or 
value. (Sheldon & Elliot, 1999). Similarly, goals that are about moving towards a 
desirable outcome, known as ‘approach’ goals, are associated with higher levels of 
well-being than those which are about preventing undesirable outcomes, known as 
‘avoidance’ goals (Elliot & Church, 1997). 
Imagining achieving those goals: Born from the model of fantasy realisation 
(Oettingen, Hönig, & Gollwitzer, 2000) the use of imagery has been shown to 
create strong goal commitments (Oettingen, Mayer, & Thorpe, 2010). Specifically, 
imagining what it would be like to achieve that goal, then identifying what is 
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currently preventing progress towards goal achievement, has been shown to 
increase goal motivation and facilitate action initiation. Research has shown that 
adults who were more skilled at envisaging positive future opportunities 
experienced a greater sense of purpose and well-being (Schmitt, Zacher, & Lange, 
2013). 
 
Planning and taking actions towards them. Research stresses that the 
experienced progress towards life goals influences subjective well-being. In a study 
of neurological patients, researchers found that highly important life goals only 
increase subjective well-being through perceived progress (Conrad, Doering, Rief, 
& Exner, 2010). Similarly, in a sample of people with enduring mental illness, 
increases in well-being constructs were reliant on perceived progression towards 
goal attainment (Clarke, Oades, Crowe, Caputi, & Deane, 2009). Planning and 
taking action towards goals is thought to increase well-being through thinking 
positively about the future and daily activity-based experiences of autonomy, 
competence, and relatedness that accumulate during the period of striving. This 
theory was supported by MacLeod and Conway (2005) who found that the number 
of planned steps taken to achieve goals was linked to thinking positively about the 
future, which in turn was associated with high positive affect and life satisfaction. 
Skills in planning such as identifying achievable planned steps are therefore crucial 
for people to feel as though their goals are attainable and that they are making 
progress. 
 
Overcoming obstacles to progress. Although making progress towards goals is 
strongly related to well-being in and of itself, the actual attainment of goals is also 
related to higher well-being (Klug & Maier, 2015). In their dual process model, 
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Brandtstädter and Rothermund (2002) propose that individuals take two 
approaches to life goals that are difficult to obtain. Assimilation mode refers to 
making active corrective interventions to plans or one’s behaviour to make 
achieving the goal more likely. At times, however, it is impossible for a person to 
make further progress toward a goal because it is not attainable due to a lack of 
necessary skills or opportunities, or changes in circumstance that deplete 
resources or opportunities such as ill health. In the dual process model, the 
process of adjusting or replacing goals that have become unattainable is named 
‘accommodation’.  
 
Accommodation has been found to play a meaningful role in the well-being of 
individuals who experience unattainable goals (Brandtstädter & Rothermund, 2002; 
Wrosch et al., 2013) through facilitating the abandonment of futile endeavours 
(goal-disengagement), and through promoting the pursuit of new meaningful 
activities (goal-reengagement). Specifically, goal-disengagement can 
prevent/reduce the experience of repeated failure and associated negative aspects 
of well-being such as negative affect, and goal-reengagement promotes positive 
aspects of well-being such as positive affect and a sense of purpose.  Goal-setting 
and planning are cognitively based processes that can be targeted in interventions 
and interventions that aim to enhance these skills have been shown to increase 
well-being and reduce depression and anxiety symptoms (Cheavens, Feldman, 
Gum, Michael, & Snyder, 2006).  
 
Goal-setting and Planning (GAP) Intervention 
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One such intervention devised by MacLeod, Coates, and Hetherton (2008), is the 
‘Goal-setting and Planning’ (GAP) intervention. GAP is designed to increase well-
being by helping individuals identify and work towards positive life goals through 
teaching goal-setting and planning skills. The techniques taught in GAP relate 
directly to the knowledge derived from the empirical literature described in the 
previous section. GAP has six modules that cover making goals and selecting self-
concordant approach goals to work towards, daily imagery, developing specific and 
realistic planned steps to achieve chosen goals, identifying and overcoming 
obstacles, accommodation, and maintaining progress. Throughout the modules, 
psychoeducation is given about the link between goals, planning and well-being.  
GAP was initially devised as a group intervention and was successful in this format 
in increasing well-being in general community samples (MacLeod, Coates, & 
Hetherton, 2008), those with long term mental health problems (Farquharson & 
MacLeod, 2014), and those in a forensic setting (Ferguson, Conway, Endersby, & 
MacLeod, 2009). GAP has also been evaluated as a self-help intervention. 
MacLeod et al. (2008) recruited participants from the general population to work 
individually through the GAP manual over five weeks, with the support of four brief 
telephone calls. Compared with controls, GAP participants showed a significant 
increase in positive affect and life satisfaction and a significant decrease in 
negative affect. A similar result was found with a sample of people with moderate-
severe depressive symptoms, with the support of only one telephone call. Within a 
cross-over design, the whole sample that received GAP saw significant increases 
in positive affect and life satisfaction and significant decreases in negative affect 
and depression pre-post intervention, that was maintained at five-week follow-up 
(Coote & MacLeod, 2012). Most recently, GAP was trialled in a self-help format 
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with non-clinical sample of working adults and found significant increases in PA 
and flourishing compared to controls (Oliver & MacLeod, 2018). The results from 
the three studies just described suggest that the GAP intervention is an effective 
self-help intervention to increase well-being for community samples and those with 
depression. Its effectiveness is yet to be tested in those with a long-term physical 
health condition.  
GAP for people with MS 
Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous 
system, which is characterised by focal plaques of demyelination and axonal loss 
in the brain and spinal cord. In addition to focal plaques, there is global 
neurodegeneration in the brain and spinal cord (Lassmann, 2018), and the 
changes gradually result in brain tissue loss and atrophy (Mahad et al., 2015). The 
damage results in wide-ranging symptoms of physical disability and 
neuropsychiatric symptoms.  
As discussed in the previous chapter, the progressive and unpredictable course of 
MS and threat to personal autonomy from fatigue, disability, and functional loss can 
harm the well-being of those diagnosed (McCabe & McKern, 2002; Mullins et al., 
2001).  MS symptomatology has been hypothesised to impact on well-being via 
two mechanisms, related to 'illness intrusiveness': firstly, by reducing the 
availability of positive experiences through decreased involvements in valued 
activities, and secondly, through the reduction of personal control over important 
domains of life experience (Devins, Seland, Klein, Edworthy, & Saary, 1993). 
For those diagnosed, some premorbid important life goals may be no longer 
attainable or only within limited constraints, and current goals may get disrupted 
due to unpredictable disease progression and episodes of exacerbation. In this 
64 
 
way, people with MS are at particular risk of experiencing psychological distress 
through a perceived failure of achieving goals, and this can undermine the 
individual's optimism or enthusiasm for long-range planning of valued activities. In 
a recent study, 60% of people with MS reported that having MS interfered with their 
plans for the future (Lonergan et al., 2015). Goal adjustment capacities are thought 
to be especially crucial for coping and adjustment among individuals who are 
confronted with stressful life events such as ill health. For example, a study with 
female breast cancer survivors showed that goal disengagement capacities were 
associated with lower levels of daily negative affect and goal reengagement 
capacities with high levels of positive affect (Wrosch & Sabiston, 2013). Overall, 
skills in goal setting and planning appear to be very relevant for people with MS, 
and they may be a group who would particularly benefit from an intervention such 
as GAP.  
Concerning depressive symptoms specifically, results from the systematic review in 
the previous chapter suggested that there may be limitations of using SHIs for 
reducing depression for people with MS when it is not directly targeted; only two of 
the seven studies had significant decreases in depression compared to controls. A 
proposed explanation is that MS-related depression itself is a more complex 
persistent condition, meaning it may be unrealistic to expect recovery from a single 
intervention (Feinstein et al., 2014). However, there is an inverse relationship 
between successful goal pursuit and depression, and GAP in a self-help format has 
reduced depression in other populations and may, therefore, have the potential to 
reduce depressive symptoms for people with MS.  
There has been a call for treatment to focus on increased well-being for people 
with MS (Mitchell, Benito-León, González, & Rivera-Navarro, 2005). Self-help 
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interventions may be particularly relevant for this group because they foster 
autonomy, can be easily accessed by those with limited mobility and require 
minimal support. However, as discussed in the previous chapter, studies testing 
this theory are limited, and further research is needed to determine the usefulness 
of SHIs for people with MS. As far as the authors are aware, no intervention 
designed to increase well-being focussing on goal and planning skills has been 
evaluated in this population.  
Outline of the current study 
The aim is to establish whether an online self-help intervention that teaches goal 
setting and planning skills can improve well-being and reduce depression in a 
sample of people with MS and whether any improvement is maintained over time. 
A sample of participants with MS were randomly allocated to receive GAP or to a 
WLC group. Measures of well-being and depression were taken at three time 
points; at baseline, post-intervention, and at eight weeks follow-up. After the follow-
up measures, the WLC group were given access to GAP. Changes over time in 
well-being and depression were compared between the two groups. 
The hypotheses predict that GAP participants, relative to controls, will show: 
1) Increases in positive affect and decreases in negative affect on the I-PANAS -SF 
2) Increases in flourishing on The Flourishing Scale 
3) Increases in QOL on the Emotional Well-being, Family/Social well-being and 
General Contentment subscales of the FAMS 
4) Decreases in depressive symptoms on the PHQ9 
 
It is also predicted that Intervention effects will be maintained over the 8-week 
follow-up 
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Method 
 
Research Approval 
Ethical approval was obtained from the research ethics committee at Royal 
Holloway, University of London. The protocol did not involve recruitment from NHS 
sites and therefore ethical approval was not sought from the NHS Health Research 
Authority. 
Design 
A randomised controlled design was employed. Once recruitment saturation had 
occurred, the final sample of participants who had completed the online consent 
form were randomly assigned to the intervention group or the wait-list control 
(WLC) group using a random number generator function in Excel.  
Participants 
Between June 2018 and September 2018, a total of 61 people with MS were 
recruited; three dropped out before baseline measures and therefore a final sample 
of 58 participants entered the study. Twenty-nine were randomised to the 
intervention group (5 males, 24 females, mean age 52 SD=11.9) and 29 were 
randomised to the WLC group (10 males, 19 females, mean age = 48 SD=11.7). 
Further demographic and Baseline characteristics of the sample can be found in 
Table 2, and the number and reason for dropouts are described in Figure 3, 
Results section.  
Recruitment 
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Individual MS centres that were members of ‘Multiple Sclerosis National Therapy 
Centre (MSNTC)’ in the United Kingdom (UK) were identified from the MS National 
Therapy Centres website and contacted via telephone to ask if they would be 
interested in circulating information about the study to their members. MSNTC is a 
membership organisation, created by the member centres and is a registered 
charity in England & Wales and Scotland.  Individual MS support groups, identified 
through the MS Society website, were also contacted via telephone. One hundred 
and twenty two MS Centres and MS support groups were contacted in total; of 
these 22 did not answer and did not respond to an initial answer machine 
message; 43 were initially contactable but either declined or contact was 
subsequently lost; and 57 agreed to circulate the study advert either in a 
newsletter, on social media or by putting up a poster. In addition to contacting MS 
Centres and support groups, the study advert was shared on social media by the 
organisations MS Trust, MS UK, and MS Research. Recruitment efforts ended on 
31st August 2018 after no further MS Centres or support groups could be identified 
to contact.  
The study advert (Appendix A) included a brief description of the study and a link to 
an online participant information sheet (PIS; Appendix B). The PIS included a 
detailed description of the study, the researchers contact details for further 
information, and a link to the online consent form (Appendix C) for people to opt 
into the study. Once they had signed the consent form, the participant was sent an 
email thanking them for signing up to the study and advising that they will be 
contacted at the start of the study to let them know what group they had been 
randomised to. 
Inclusion and Exclusion Criteria 
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Inclusion criteria and exclusion criteria were deliberately kept minimal to not restrict 
a specific population which may have resulted in a sample size that was too small, 
and to increase external validity. The inclusion criteria applied were a) a diagnosis 
of MS as identified by the participant, b) fluency in English, and c) consent to 
inform their GP of their participation in the study. There were no exclusion criteria 
applied. 
Power Analysis 
A previous study that evaluated the effectiveness of the GAP intervention within a 
population of people with depression was used to estimate effect sizes for the 
current study. The researchers reported medium to large effect sizes (partial n²  
0.058 to  partial n² = 0.106; (Coote & MacLeod, 2012), and on this basis, a medium 
to large effect size was estimated for the current study. With power at .80, alpha of 
0.05 (Cohen, 1992), and predicting a medium to large effect size using a three 
(time: baseline, post intervention, six-week follow up) x two (Group: Intervention or 
WLC) mixed ANOVA design, a total sample of 52 participants was required to 
ensure the study was sufficiently powered to detect significant change within and 
between conditions. The actual sample obtained (i.e. that completed measures at 
all three timepoints) was 42.  
Measures and materials 
A total of four measures were used in the study (see Appendices D - G). A 
description of each of these is presented below. The measures were chosen to 
capture depression, different aspects of well-being including positive affect, 
negative affect, quality of life, and positive functioning. Socio-demographic 
information was collected for each participant at baseline only. This included age, 
gender, ethnicity, MS Type, disease duration and GP.   
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The Positive and Negative Affect Scale Short Form (I-PANAS-SF; 
Thompson, 2007). 
The I-PANAS-SF measures the affective component of well-being consisting of 10 
affect adjectives for which the participant indicates the extent to which they “feel 
this way generally” from 1 = “very slightly or not at all” to 5 “extremely”. The scale 
yields two sub-scales of–positive affect and negative affect. Correlations between 
the original scales and their short counterparts were r=0.92 and r=0.95 for positive 
and for negative affectivity respectively, indicating they preserve the validity and 
reliability of the original measure (Mackinnon et al., 1999; Thompson, 2007). 
Internal consistency is good for the positive scale (a = .73-.79) and acceptable for 
the negative scale (a = .65-.67), and reliability is adequate with Cronbach alpha 
values of the short negative and positive affectivity scales of .80 (Gyollai, Simor, 
Koteles, & Demetrovics, 2011). 
 
The Flourishing Scale (Diener et al., 2010). 
The Flourishing Scale measures the cognitive component of well-being, providing a 
general overview of the individual’s self-perceived success in areas such as 
relationships, self-esteem, purpose, meaning and optimism. It consists of 8 
statements for which the participant indicates their agreement on a Likert scale 
from 1 strongly disagree to 7 strongly agree. All items are phrased in a positive 
direction, for example “I lead a purposeful and meaningful life”. Scores can range 
from 8 (Strong Disagreement with all items) to 56 (Strong Agreement with all 
items). High scores signify that respondents view themselves in positive terms in 
important areas of functioning. The measure has good psychometric properties; 
when validated in a non-clinical sample, the Flourishing Scale demonstrated good 
internal reliability, with alpha coefficients ranging from .85 to .86 across the items. It 
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was also shown to have high convergence with other psychological well-being 
scales; the Ryff Scales of Psychological Well-being (a = .78) and Deci and Ryan’s 
Basic Need Satisfaction in General scale and (a = .73) (Diener et al., 2010). 
 
Patient Health Questionnaire (Kroenke, Spitzer, & Williams, 2001).  
The PHQ-9 is a nine item self-report measure  in which respondents indicate how 
often in the past two weeks they have been bothered by certain depressive 
symptoms using a Likert Scale from 0 (Not at all) to 3 (Nearly every day), for 
example “feeling down, depressed or hopeless”. The scores range from 0-27, with 
higher scores indicating greater severity. It has been shown to have excellent 
Internal reliability (a = 0.86 – 0.89) and test re-test reliability (correlation = 0.84). In 
terms of validity, sensitivity has been shown to be between 68% and 95% and 
specificity between 84% and 95%, and scores show significant correlation with the 
mental health subscale of the SF20 QOL scale (Kroenke et al., 2001).  
 
The Functional Assessment of Multiple Sclerosis (Cella et al., 1996).  
The FAMS is a QoL instrument developed for use with people with MS. It has 44 
items across six subscales: mobility, symptoms, emotional well-being, general 
contentment, thinking/fatigue, and family/social well-being. Participants are asked 
to indicate the extent to which statements applies to them in the past 7 days on a 
Likert scale from 0 ‘Not at all’ to 4 ‘Very Much’. Example statements from each 
respective subscale are as follows: I have trouble walking; I have pain; I feel 
trapped by my condition; I have accepted my illness; I have a lack of energy; I feel 
close to my friends.  It has shown to have high internal consistency and test-retest 
reliability ranging from 0.85 to 0.91; concurrent and construct validity; and 
psychometrically and conceptually distinct subscales (Cella et al., 1996). The 
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Mobility subscale was shown to have high correlation in a clinical sample with the 
physical component summary (PCS) score of the SF-36 QOL scale (r = 0.62) and 
the EDSS (r = 0.68); the Symptoms subscale had a moderate correlation with the 
Multiscale depression inventory (MDI) Vegetative subscale (r = 0.62) and PCS 
score of the SF-36 QOL scale (r = 0.56); the Emotional Well-being subscale 
correlated with the HADS depression score (r = -0.58), as did the General 
Contentment subscale (r = -0.71); the Thinking/Fatigue subscale correlated with 
MDI Vegetative subscale (r = 0.66); and the Family/social well-being subscale 
correlated with HADS Depression score (r = -0.52) and MDI Evaluative score (r = -
0.59). 
 
The Intervention 
The GAP intervention was branded “Valuing Goals” for purposes of the study. The 
Valuing Goals programme was in a pure self-help internet-based format and was 
made available online through a website created in WordPress content 
management system (Appendix H). WordPress is a widely used online, open 
source, website creation tool written in PHP, and has been used as a platform for 
the programme in previous studies. The programme consists of six modules, with 
downloadable worksheets to back up its structured exercises and tasks. The six 
modules are as follows: 
Module 1: Concepts of well-being, goals and plans and selecting self-concordant 
goals.  
Module 2: Imagining achieving goals over several days.  
Module 3: Developing plans for how to achieve one’s goals.  
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Module 4: Identifying and overcoming obstacles, pros and cons of one’s planned 
steps.  
Module 5: Putting into practice what’s been learnt in the preceding modules over 
one week. 
Module 6: Review progress and key points on how to maintain progress.  
 
With guidance from an individual with MS minor adjustments were made to the 
wording and examples used in the programme to make it more acceptable and 
relevant for people with MS. Feedback for acceptability and ease of use of the final 
website was sought from the same individual with MS and a physiotherapist for 
people with MS. Feedback for the website content was positive and no further 
changes were sought, and for the website functionality one issue was highlighted 
and subsequently changed which was for the questionnaires to open in a new tab 
instead of navigating away from the Valuing Goals website. 
 
Procedure 
Participants GPs were notified by the researcher of their patient’s involvement in 
the study by email or fax. Each participant was allocated an anonymised participant 
identification (ID) number which was used to amalgamate their demographic, 
baseline and follow-up data. The name and ID number pairings were kept with 
contact details in separate encrypted and password-protected spreadsheets. 
Participants were also given an individual username and password to log into the 
Valuing Goals website, where they could access the programme material and 
measures.  
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All participants were asked to complete the outcomes measures (I-PANAS-SF; FS; 
PHQ9; FAMS) at three time points: before the intervention group started the 
programme (Baseline), when the intervention group ended the programme (Time 
1), and at 8-week follow-up (Time 2). The measures were identical at all time 
points. All data were collected through Google Forms, a password protected online 
survey system.  After Time 2, the WLC group were given access to the programme 
without any further involvement with the researcher. The study timeline for the two 
groups is depicted in Figure 2.  
 
 Week 1 
 
Weeks 2-6 Week 6 Weeks 7-
14 
Week 14 Week 15 
Intervention 
Group 
Baseline 
Measures 
 
Valuing 
Goals 
programme 
Time 1 
Measures 
8-week 
Follow-up 
period 
Time 2 
Measures 
End of 
Study 
WLC Group Baseline 
Measures 
 Time 1 
Measures 
 Time 2 
Measures 
Given 
access to 
GAP 
Figure 2. Study Timeline 
 
If a participant indicated suicidal thoughts by scoring on the PHQ9 risk question at 
any time point they were called to ask permission to send their PHQ9 results to 
their GP, and then the results were emailed or faxed to their GP to follow up. 
 
The researcher called all participants 1-2 weeks after they were emailed their 
website logins to answer any questions and resolve any technical issues. The 
researcher sent email prompts to participants when they were due to complete the 
measures at all time points. A written prompt within the last programme module 
reminded participants in the intervention group to complete their Time 1 measures 
after completing the programme, the timing of which could differ between 
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individuals. If, however, they had not completed the measures after 8 weeks, an 
email reminder was sent by the researcher. In previous studies using the 
programme, adherence data revealed that there was a drop off in adherence after 
Module 3 and therefore in this study a ’keeping up momentum’ email was sent to 
those in the intervention group at the estimated mid-way point with the aim of 
encouraging continued participation in the programme (Appendix I).  
At completion, all were thanked for their participation and those in the WLC group 
were given access to the Valuing Goals programme. All participants were entered 
into a prize draw to win one of two £50 Amazon vouchers. 
The use of a computerised random generator for randomisation ensured that the of 
bias being introduced in the process was low (random sequence generation and 
allocation concealment). Blinding to group was not possible due to the nature of the 
intervention. All data were collected online and so no bias could be introduced 
during data collection. Incomplete outcome data was addressed using an intention 
to treat principle and all outcomes were reported.  
 
Results 
Overview 
All statistical analyses were conducted using the Statistical Package for Social 
Sciences version 21.0 (SPSS; version 21.0). Descriptive statistics are reported to 
one decimal place, statistical results are reported to two decimal places, and exact 
p- values are given. The threshold for statistical significance was set at p < .05, and 
hypothesis testing was two-tailed. Effect sizes were calculated for all main analysis 
results; Partial eta-squared (ηp2) = 0.01 was considered small, ηp2 = 0.06 medium, 
and ηp2 = 0.14 large. Where assumptions for parametric tests were met then they 
75 
 
were used, but where they were not then non-parametric tests were used. 
Continuous clinical characteristics and baseline scores are summarised by means 
and SD. Categorical clinical characteristics are described by frequencies and 
percentages. The screening of the data including normality of distributions and the 
management of outliers and missing data are described. Treatment effects were 
examined using a two (treatment condition) x three (Time) analysis of variance 
(ANOVA), and results are reported for each outcome variable. In line with an 
intention to treat (ITT) analysis all primary analysis was completed using data from 
the full sample (N=58). 
Missing Data 
Data were missing at time points due to participants not responding to prompts 
(dropouts) or withdrawing from the study. There were no individual missing data 
values within completed measures. A consort diagram, Figure 3, below, illustrates 
the flow of participants through the study including dropouts and missing data. 
Forty-two (72.4%) participants provided complete data, and 16 (27.6%) participants 
had missing data from one or more time point. Overall, 14.1% of data was missing 
from the dataset, whilst 20.7% of data was missing at Time 1 and Time 2 follow-up. 
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Figure 3. Consort diagram of participant flow 
 
An overview of the descriptive statistics for demographic information at baseline for 
participants who completed and those with missing data are presented in Table 3. 
Chi-Square revealed that those with missing data were significantly more likely to 
be in the intervention group rather than WLC (ꭓ² (1, N=58) = 8.63, p = .007), but 
they did not significantly differ from those with complete data on any other baseline 
demographic or clinical variables. A Missing at Random (MAR) assumption was 
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made, and the possibility of an interaction effect involving randomised group was 
accounted for in the MI method employed, described below.  
Multiple Imputation (MI) method (Rubin, 2004) was used to manage missing data 
to allow for an ITT approach for primary analysis. MI was favoured over other 
methods as it can use information from partially observed cases to better predict 
imputations in analysis of  datasets with several follow-ups (Bell & Fairclough, 
2014). Imputed missing scores were conducted for Intervention group and WLC 
group separately which produces unbiased results when there is a possible 
interaction effect involving the randomised groups, and has been shown to be more 
robust than conducting MI for an overall sample in RCTs (Sullivan, White, Salter, 
Ryan, & Lee, 2018). 
All demographic, baseline and outcome variables were included as predictors in 
the single imputation model for each group, so that any possible associations 
between related outcomes could aid imputation. As such, predictors in the model 
were: age, sex, MS type, disease duration; baseline, Time 1 and Time 2 total 
scores for the I-PANAS-SF positive, I-PANAS-SF negative, PHQ9, FS, FAMS Total 
and FAMS subscales (mobility; symptoms; emotional well-being; general 
contentment; thinking/fatigue; family/social well-being). Minimum and maximum 
values were entered based on the possible minimum and maximums for each 
variable. In SPSS the random number generator function was used to set the 
random seed; Mersenne Twister was selected, and the starting point was set at the 
default fixed value of 2000000. The number of imputations was set to 15 based on 
recent guidelines suggesting the number of imputations should be equal or greater 
to the overall percentage of missing data in the dataset. Maximum case draws 
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were set to 100 and maximum parameter draws set to 50. All primary analysis 
results are reported using pooled statistics from the 15 MI datasets. 
Outliers 
Frequencies and boxplots of all variables were examined to identify any extreme 
outliers, defined as values that were more than three standard deviations away 
from the variable mean for each group (Field, 2005). Three data points were 
identified that belonged to the same participant for Baseline PANAS Negative, 
Time 1 FAMS Symptoms, and Time 1 FAMS Total score. Two-sided winsorizing 
set at 99.7% was used to change the extreme outliers (n=3), in which they were 
transformed to the value of the next score plus one unit of measurement.  
Distribution 
The z-scores were calculated and examined for each variable to ascertain any 
skewness and kurtosis. A distribution was considered normal if a z-score was less 
than 2.58 and considered slightly skewed or kurtosed but still acceptable for 
parametric tests if less than 3.29. The PANAS Negative at Time 2 for the control 
group was positively skewed (Z-score = 3.34). All other variables were found to 
have acceptable levels of skew and kurtosis. As skewness for The PANAS 
Negative was only 0.05 over the threshold it was decided to consider all variables 
as meeting the assumptions for using parametric statistical analysis. 
Socio-demographic and baseline characteristics of sample 
Table 1 provides the socio-demographic information for randomised groups and 
total sample and Table 2 provides the baseline characteristics. Independent t-tests 
revealed that those in the intervention group had had MS for significantly longer 
than those in the control group (mean difference = 5.2 years, t(55) = 2.13, p = 
79 
 
.033). There were no other significant differences between groups. Participants 
with complete data were also compared with those who dropped out on socio-
demographic and baseline characteristics, and no significant differences were 
found on any of the variables measured. 
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Table 3 
Demographic information; comparing intervention versus control and completers versus 
dropouts 
 
 
Intervention 
Group 
(n=29) 
Control 
Group 
(n=29) 
Total 
Sample 
(n=58) 
Difference 
(p value) 
Completers 
(n=42) 
Dropouts 
(n=16) 
Difference 
(p value) 
Sex 
(Female) 
24  
(83) 
19  
(66) 
43  
(74) 
0.23 30  
(71.4) 
13  
(81.3) 
0.343 
Age (years) 52  
(11.9) 
48.2 
(11.7) 
50.1 
(11.9) 
0.221 49.2  
(11.9) 
52.5 
(11.8) 
0.357 
MS Type    0.315   0.58 
Primary 
Progressive 
4  
(14) 
5  
(17) 
9  
(15.5) 
 7  
(16.7) 
2  
(13.3) 
 
Relapsing-
Remitting 
12  
(43) 
18  
(62) 
30  
(53) 
 23  
(54.8) 
7  
(46.7) 
 
Secondary 
Progressive 
11  
(39) 
5  
(17) 
16  
(28) 
 10  
(23.8) 
6  
(40) 
 
Unsure 
1 
 (4) 
1  
(4) 
2  
(4) 
 2  
(4.8) 
0 
(0) 
 
MS 
Duration 
15.6  
(9.8) 
10.4  
(8.6) 
13.0  
(9.5) 
0.033* 12.0  
(9.3) 
15.8  
(9.8) 
0.18 
Ethnicity    0.368   0.263 
White 27  
(93) 
29  
(100) 
56  
(97) 
 42 
 (100) 
14  
(87.5) 
 
Other 1  
(3) 
0 
(0) 
1  
(2) 
 0 
(0) 
1  
(6.3) 
 
Missing 1  
(3) 
0 
(0) 
1  
(2) 
 0 
(0) 
1  
(6.3) 
 
 
            Note. Bold* = significant at the <.05 level 
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Table 4 
Baseline measures; comparing intervention versus control groups and completers versus 
dropout 
 
Intervention 
Group 
(n=29) 
Control 
Group 
(n=29) 
Total 
Sample 
(n=58) 
Difference 
(p value) 
Completers 
(n=42) 
Dropouts 
(n=16) 
Difference 
(p value) 
PHQ9 score 
8.9 
(5.5) 
8.5 
(5.5) 
8.7 
(5.4) 
0.745 8.7 
(5.6) 
8.7 
(5.0) 
.968 
Depressed 
(PHQ9=>10) 
12 
(41.4) 
10 
(34.5) 
22 
(37.9) 
0.787 15 
(35.7) 
6 
(40) 
.766 
FAMS Total 
94.5 
(31.9) 
102.5 
(30.4) 
98.5 
(31.1) 
0.320 99.9 
(31.9) 
95.3 
(29.6) 
.631 
Mobility 
9.8 
(6.8) 
13.2 
(7.9) 
11.5 
(7.5) 
0.077 11.9 
(7.9) 
10.5 
(6.2) 
.542 
Symptoms 
20.7 
(5.7) 
21.2 
(4.4) 
20.9 
(5.0) 
0.689 21.6 
(4.8) 
19.1 
(5.5) 
.098 
Emotional 
Wellbeing 
18.2 
(6.8) 
18.2 
(6.9) 
18.2 
(6.8) 
0.975 18.1 
(7.3) 
18.5 
(5.6) 
.876 
Contentment 
14.5 
(6.3) 
14.2 
(6.6) 
14.4 
(6.4) 
0.859 14.3 
(6.6) 
14.7 
(5.9) 
.837 
Thinking and 
Fatigue 
14.9 
(9.7) 
16.9 
(7.9) 
15.9 
(8.8) 
0.374 16.1 
(8.7) 
15.4 
(9.2) 
.802 
Family and 
Social 
16.5 
(7.6) 
18.8 
(6.6) 
17.7 
(7.1) 
0.231 17.8 
(7.2) 
17.1 
(7.0) 
.747 
PANAS 
Positive 
15.0 
(3.8) 
14.1 
(4.0) 
14.6 
(3.9) 
0.345 14.1 
(3.9) 
15.6 
(3.6) 
.216 
PANAS 
Negative 
9.4 
(3.9) 
9.8 
(4.0) 
9.6 
(4.0) 
0.668 9.5 
(3.8) 
10.0 
(3.0) 
.630 
Flourishing 
Scale 
38.9 
(9.8) 
38.3 
(11.7) 
38.6 
(10.7) 
0.816 38.5 
(10.7) 
38.8 
(11.3) 
.938 
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Well-being outcomes 
A 2 (treatment vs control) x 3 (Time 1, Time 2, Time 3) repeated measures ANOVA 
was employed to look at differences between the groups over the three time 
periods on the I-PANAS-SF, Flourishing Scale, PHQ9, and the FAMS. An overview 
of descriptive statistics for clinical variables at baseline and follow-up is presented 
in Table 5.  For the Symptoms subscale of the FAMS Mauchly’s test indicated 
violation of sphericity (χ²(2, N=58) = 9.32, p = 0.016) and as Green-Geisser Epsilon 
was >0.75 (p = 0.87), Huynh-Feldt results are reported. No violation of sphericity 
was indicated for any other variables. 
 
The intention to treat primary analysis yielded a non-significant result for group x 
time interactions on all outcomes measures supporting the null hypothesis of no 
treatment effect. There was a trend towards a treatment effect favouring Valuing 
Goals on the family/social well-being subscale of FAMS with a small to medium 
effect size but this was non-significant (F(2,112) = 2.60, p = .088, ηp2= 0.04). All 
other measures yielded a small effect size for time x group interactions (ηp2 range = 
.01 - .03), except for PANAS Negative which had very small effect size (ηp2 = .001). 
There was a trend towards a main effect of time on the Flourishing Scale but this 
was also non-significant (F(2,112) = 2.96, p = .063). There was a significant main 
effect of Time on PANAS Negative with a medium effect size (F(2,112) = 4.34, p = 
.018, ηp2= 0.07) and PHQ9 with a small effect size (F(2,112) = 0.97, p = .005, ηp2 = 
0.02).  
Paired t-tests revealed that PANAS Negative scores were significantly lower at 
Time 2 compared to baseline (mean difference = -1.29, t(57) = -2.76, p = .008), but 
not did not differ significantly between Baseline and Time 1 (mean difference = -
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0.85, t(57) = -1.83 p = 0.08), or Time 1 and Time 2 (mean difference = -0.44, t(57)  
= -1.09, p = .30). Paired t-tests revealed that PHQ9 scores were significantly lower 
at Time 1 compared to Baseline (mean difference = -1.65, t(57) = -2.46, p = .018), 
and at Time 2 compared to baseline (mean difference = -1.98, t(57) = -2.89, p = 
.004). They did not differ significantly between Time 1 and Time 2 (mean difference 
= -.33, t(57) = -.59, p = .56). 
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Table 5  
Results of ITT 2x3 repeated measures ANOVA 
 Intervention (N=29) Controls (N=29) P Value 
 
Baseline Time 1 Time 2 Baseline Time 1 Time 2 
Time x 
Group Time Group 
FAMS Total 
94.7 
(31.3) 
101.2 
(29.2) 
100.1 
(27.8) 
102.5 
(30.4) 
103.6 
(20.0) 
105.9 
(26.1) 
.561 .180 .445 
Mobility 
9.7 
(6.7) 
10.4 
(6.5) 
10.5 
(5.8) 
13.2 
(7.9) 
12.6 
(6.6) 
13.4 
(6.9) 
.243 .592 .110 
Symptoms 
20.8 
(5.6) 
21.6 
(5.0) 
21.1 
(4.5) 
21.2 
(4.4) 
21.3 
(3.2) 
20.6 
(4.1) 
.543 .382 .905 
Emotional 
Wellbeing 
18.2 
(6.7) 
19.3 
(6.0) 
18.1 
(6.5) 
18.2 
(6.9) 
18.7 
(5.3) 
19.4 
(5.4) 
.380 .470 .837 
Content-
ment 
14.7 
(6.2) 
15.1 
(5.4) 
14.7 
(5.7) 
14.2 
(6.6) 
14.6 
(5.3) 
15.7 
(5.9) 
.339 .419 .944 
Thinking/ 
Fatigue 
14.8 
(9.5) 
16.4 
(8.2) 
17.0 
(8.4) 
16.9 
(7.8) 
16.5 
(6.8) 
18.3 
(7.1) 
.578 .177 .517 
Family/ 
Social 
16.5 
(7.5) 
18.3 
(5.3) 
18.7 
(5.5) 
18.8 
(6.6) 
18.3 
(5.7) 
18.6 
(6.7) 
.088 .255 .635 
PANAS  
Positive 
15.0 
(3.8) 
15.8 
(2.9) 
14.6 
(3.3) 
14.0 
(4.0) 
14.7 
(4.0) 
14.9 
(4.7) 
.392 .268 .462 
PANAS 
Negative 
9.5 
(3.7) 
8.8 
(3.3) 
8.2 
(2.7) 
9.7 
(3.5) 
8.8 
(3.0) 
8.4 
(2.9) 
.895 .018* .839 
PHQ9 
8.9 
(5.4) 
6.5 
(4.2) 
6.5 
(4.1) 
8.5 
(5.5) 
7.6 
(4.4) 
7.0 
(3.6) 
.392 .005* .674 
Flourishing 
Scale 
39.0 
(9.7) 
41.2 
(7.4) 
42.2 
(7.8) 
38.3 
(11.7) 
39.3 
(10.5) 
39.9 
(10.5) 
.681 .063 .471 
 
        Note.  Bold* = significant at the <.05 level 
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Modified ITT Analysis 
 
A modified ITT analysis was conducted in which only completers were included 
(those who completed measures at all three time points), and those who reported 
they completed two or fewer modules were excluded (N = 1). Results are reported 
in Table 4. Mauchly’s test indicated violation of sphericity For the Emotional Well-
being subscale of the FAMS (χ²(2, N = 41) = 7.91, p = .019) and the PANAS 
Positive (χ²(2, N = 41) = 9.7, p = .008) and as Greenhouse-Geisser Epsilon was 
>0.75, Huynh-Feldt results are reported for both. No violation of sphericity was 
indicated for any of the other variables.  
 
There was a significant effect of Time on FAMS Total score with a medium effect 
size (F(2, 40) = 3.35, p = .04, ηp2 = .08), Thinking and Fatigue subscale with a 
medium effect size (F(2, 40) = 3.41, p = .038, ηp2 = .08), and PHQ9 with a medium 
to large effect size (F(2, 40) = 3.89, p = .024, ηp2= .09).  
 
Paired t-tests revealed that for the whole sample PHQ9 scores at Time 2 were 
significantly lower than at baseline (mean difference = -1.88, t(40) = -2.3, p = .027). 
The differences were non-significant between baseline and Time 1 (mean 
difference = -1.54, t(40) = -1.85, p = .072) and between Time 1 and Time 2 (mean 
difference = -.34, t(40) = -.49, p = .63). Paired t-tests revealed that for the whole 
sample FAMS Total scores did not significantly differ between any time points 
(Baseline to Time 1: mean difference = 3.79, t(40) = 1.4, p = .16; Time 1 to Time 2: 
mean difference = 0.57, t(40) = .26, p = .795; Baseline to Time 2: mean difference 
= 4.4, t(40) = 1.6, p = .112). Similarly, no significant differences between time 
points were found for the Thinking and Fatigue subscale (Baseline to Time 1: mean 
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difference = 0.58, t(40) = .57, p = .566; Time 1 to Time 2: mean difference = 1.2, 
t(40) = 1.4, p = .162; Baseline to Time 2: mean difference = 1.8, t(40) = 1.69, p = 
.092). 
 
There was a significant group x time interaction effect for the Family and Social 
well-being subscale with a large effect size (F(2, 40) = 4.65, p = .012, ηp2 = .12). 
One-way repeated measures ANOVA were conducted for each treatment group, 
which indicated significant differences over time for the intervention group with a 
very large effect size (F(2, 14) = 4.56, p = .02, ηp2 = .25) but not the control group 
(F(2, 25) = .46, p = .64, ηp2 = .02). Paired t-tests revealed the intervention group 
scores significantly increased from baseline to Time 1 (mean difference = 2.73, 
t(14) = 2.43, p = .029) and the difference was maintained at time 2 (mean 
difference = 2.73, t(14) = 2.25, p = .041).  
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Table 6  
Results of Modified ITT analysis 2x3 repeated measures ANOVA 
 Intervention (n=15) Controls (n=26) P Value 
 
Baseline Time 1 Time 2 Baseline Time 1 Time 2 
Time x 
Group Time Group 
FAMS Total 
96.5 
(36.8) 
103.9 
(35.9) 
106.0 
(35.4) 
102.6 
(29.6) 
103.6 
(21.1) 
105.9 
(24.4) 
.346 .040* .837 
Mobility 
10.9 
(8.2) 
11.6 
(8.2) 
11.6 
(7.5) 
12.6 
(7.9) 
12.6 
(7.0) 
13.1 
(6.4) 
.787 .550 .559 
Symptoms 
22.2 
(5.8) 
21.8 
(6.0) 
21.7 
(5.8) 
21.4 
(4.2) 
21.4 
(3.3) 
20.5 
(4.2) 
.700 .282 .578 
Emotional 
Wellbeing 
17.7 
(7.9) 
19.7 
(7.0) 
19.5 
(7.6) 
18.3 
(7.1) 
18.7 
(5.6) 
19.4 
(5.4) 
.548 .098 .922 
Content-
ment 
14.8 
(6.7) 
15.2 
(6.6) 
15.8 
(7.2) 
14.3 
(6.7) 
14.6 
(5.6) 
15.6 
(5.8) 
.938 .136 .829 
Thinking 
and Fatigue 
15.4 
(9.5) 
17.4 
(9.2) 
19.2 
(9.8) 
17.1 
(7.9) 
16.5 
(7.1) 
18.5 
(6.6) 
.402 .038* .983 
Family/ 
Social 
15.5 
(8.5) 
18.2 
(6.5) 
18.2 
(6.9) 
19.0 
(6.2) 
18.4 
(6.0) 
18.8 
(6.6) 
.012* .093 .494 
PANAS 
Positive 
14.4 
(4.0) 
15.8 
(3.2) 
14.8 
(4.2) 
14.0 
(4.0) 
14.7 
(4.1) 
14.8 
(4.2) 
.568 .158 .683 
PANAS 
Negative 
9.6  
(4.38) 
8.6 
(3.68) 
8.33 
(3.47) 
9.5 
(3.5) 
8.8 
(3.2) 
8.4 
(3.0) 
.890 .110 .942 
PHQ9 
9.3 
(5.9) 
6.2 
(5.3) 
6.7 
(5.4) 
8.3 
(5.7) 
7.7 
(4.6) 
6.9 
(3.6) 
.307 .024* .865 
Flourishing 
Scale 
39.5 
(9.7) 
40.5 
(7.9) 
41.9 
(10.6) 
38.4 
(11.4) 
39.2 
(11.1) 
40.2 
(9.7) 
.945 .143 .658 
 Note. Bold* = significant at the <.05 level 
 
 
88 
 
Website analytics of participant adherence  
Analytics data from the website were analysed. As illustrated in Figure X below, 
completion rate of the modules decreased in succession from 1 to 6; 100% (N = 
29) of participants accessed Module 1, falling to 24.2% that accessed Module 6 (N 
= 7). 
 
 
Figure 4. Adherence to intervention modules 
 
Discussion 
 
Summary of the Results 
The present study aimed to determine whether an online goal-setting and planning 
(GAP) self-help intervention (MacLeod et al., 2008) could improve the well-being of 
people with MS in a randomised controlled trial. The study built on evidence from 
previous trials that showed the GAP intervention to be effective in guided self-help 
format for people with depression and in an online self-help format for non-clinical 
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working adults. A pure self-help format was employed in which participants 
received no intervention guidance, and contact was limited to one telephone call to 
address practical issues, and a ‘keeping up momentum’ email midway through the 
program. Sixty-two participants consented to take part in the study, of whom 58 
were randomised. MI was used to allow an ITT primary analysis, and a secondary 
modified ITT analysis was conducted with completers only. 
The first predicted outcome of the study, Hypothesis 1, was that, relative to 
controls, GAP participants would show significantly improved well-being post-
intervention. An improvement in well-being was defined as an increase in positive 
affect, a decrease in negative affect, an increase in flourishing, and an increase in 
quality of life related to emotional well-being, contentment, and family/social well-
being domains. This hypothesis was primarily not supported. GAP participants did 
not show a significant improvement relative to controls on any measure using an 
ITT analysis. In a modified ITT analysis, GAP participants showed significant 
improvement relative to controls in QOL in the family/social domain only. 
Hypothesis 2 was that GAP participants, relative to controls, would experience a 
significant decrease in depressive symptoms post-intervention. This hypothesis 
was not supported; both GAP and controls experienced a decrease in depressive 
symptoms. 
The final predicted outcome, Hypothesis 3, was that predicted intervention effects 
as previously outlined would be maintained at eight-week follow-up. This 
hypothesis was largely redundant due to the previous hypothesis being 
unsupported. However, in the modified ITT analysis, the increase in family/social 
QOL found was maintained at eight-week follow-up, partially supporting this 
hypothesis. 
90 
 
Unexpected results were significant decreases in depressive symptoms between 
baseline and Time 1 that were maintained at follow-up, and significant decreases in 
NA between baseline and follow-up for the whole sample. 
Baseline Characteristics 
Demographic characteristics of the current sample compared to those found in the 
literature as seen in the previous chapter. Compared to general population 
samples, baseline measures indicate that participants in the current study were 
experiencing similar levels of PA and NA, but in line with the literature experienced 
lower cognitive aspects of well-being as measured by the FS, and higher levels of 
depressive symptoms (Barak & Achiron, 2011; Bassi et al., 2014). In terms of 
depressive symptoms, although there was a wide range of scores in our sample, 
38% scored 10 or above on PHQ9 compared to around 6% in general populations 
(Kocalevent, Hinz, & Brähler, 2013; Martin, Rief, Klaiberg, & Braehler, 2006). 
Compared to other samples of people with MS, our sample had similar levels of PA 
and NA (Bassi et al., 2014), and depressive symptoms (Boeschoten, Braamse, et 
al., 2017). Quality of life as measured by the FAMS was slightly lower in our 
sample than that reported in other studies of people with MS specifically on 
subscales of mobility, general contentment, thinking and fatigue, and family/social 
well-being (Cella et al., 1996; Chang et al., 2002), which may be explained by the 
current sample having a longer disease duration. In keeping with this, our sample 
had similar mean flourishing levels as people with MS who self-reported low QOL 
in a study of newly diagnosed individuals (Strober, 2018). 
Consideration of Key Findings 
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The Comparable reduction in NA and depressive symptoms over time in the WLC 
group, and the intervention group, was unexpected; the reduction was considerable 
with medium and medium to large effect sizes respectively for the whole sample.  
Significant improvement in WLC groups is not observed in most of the literature of 
SHIs with people with MS, as seen in the previous chapter. Our findings do, 
however, resemble those of one study by Boeschoten and colleagues (2017), that 
found significant large decreases in depression in both groups, also maintained at 
follow-up. The authors ruled out several possible explanations through sensitivity 
analysis, including those related to study design, depression severity and 
measurement, and additional mental healthcare outside of the trial. One plausible 
explanation offered was that improvements were due to regression to the mean as 
high scores are more likely to decrease, and the sample consisted of people with 
moderate to severe depressive symptoms. This explanation is unlikely to fit for the 
current study because mean baseline levels of depression and NA were low. 
Another explanation discussed which could explain the current findings is that the 
WLC consisted of highly motivated individuals and enrolment in the trial acted as a 
trigger to address their issues by other means.  Additional possible factors are that 
anticipation of receiving the intervention at the end of the waiting period produced 
hope and a reduction in depressive symptoms or reduction represents the natural 
course of depressive symptoms. In the general population, half of depressed 
patients recover within three months (Spijker et al., 2002). 
The significant increase in the Family/Social subscale of the FAMS found in the 
sensitivity analysis was unusual in the fact that it occurred in the absence of any 
observable differences compared to WLC on other outcome measures. This 
subscale comprises of seven items relating to feeling close to and supported by 
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others and feeling that others understand and accept one’s illness. One 
mechanism by which improvement could have occurred is through the process of 
participants talking to family/friends about the GAP modules themselves and this 
conversation being a platform for open discussion of MS, leading to feeling more 
understood and supported. Another mechanism could be through the participant’s 
actions taken in stepped plans towards their goals, which may have involved 
initiating contact with friends/family leading to increased social contact. Research 
shows that both people in the general population and those with neurological 
disorders rate the most important life goals as those involving intimacy, suggesting 
that a large proportion of chosen goals in this study could well be relational 
(Conrad, Doering, Rief, & Exner, 2010).  
The question remains why, if GAP led to significant improvements in family/social 
QOL, did this not result in improvements on other measures. Based on the 
literature outlined in the introduction to this chapter, one would expect that 
engaging in steps towards valued goals to lead to an increase in positive emotions, 
and improvements in other areas of well-being such as feeling purposeful, 
engaged, self-efficacious, and optimistic. An explanation that could account for this 
discrepancy is that the increase in family/social well-being was a chance finding 
and not a result of the intervention.  Such a chance finding could have resulted 
from multiple testing or from the fact that in the second analysis those remaining in 
the treatment group were likely to be the more motivated people, due to most case-
wise deletions being from the treatment group, and therefore it was not a fair 
comparison. 
The only study identified in the previous chapter that used PPI methods, 
incorporated into a CBT intervention targeting depression, also had interesting 
93 
 
results concerning different domains and measures of well-being. They saw an 
improvement in the psychological well-being domain in WhoQoL-BREF which 
consists of six questions related to body image, negative feelings, positive feelings, 
self-esteem, spirituality, thinking, learning and concentration, but there was no 
improvement in the mood subscale of the HAQUAMS which includes four 
questions related to well-being of contentment, enjoyment, a sense of purpose and 
energy (Fischer et al., 2015). The results suggest that improvement in one area of 
well-being does not necessarily result in improvement in others, but the authors do 
not discuss possible mechanisms or reasons for this. 
It is also possible that the study lacked the power to detect significant differences 
between groups in other domains. In the primary ITT analysis, using MI, we had a 
large enough sample to detect medium to large effect sizes only, as indicated by 
our prospective power analysis. The modified ITT analysis was underpowered to 
detect medium to large treatment effects; differences in the family/social QOL 
subscale reached significance because it had a large to very-large effect size. 
There were small effect sizes for time x group interactions in both analyses for all 
other measures, except for NA; it is possible that with a larger sample the 
differences between groups indicated by the small effect sizes would be significant.  
Another possibility is that there indeed was no significant difference between 
groups. Previous studies of the GAP program have found it to improve well-being 
and reduce depression, raising the question of what factors could explain a no 
treatment effect in this particular group. Potential explanations are discussed 
below, including ceiling effects, difficulty accessing the intervention due to cognitive 
difficulties, and other MS-related factors resulting in the intervention being 
ineffective. 
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Non-MS-related Factors. One factor that could have influenced efficacy is that our 
sample was too heterogenous. Stringent inclusion/exclusion criteria are often 
employed in research to reduce the influence of any confounding variables and 
target those most likely to benefit from the intervention. Although a decision was 
made not to have inclusion/exclusion criteria to be as inclusive as possible, some 
of our participants were unlikely to improve due to experiencing very high levels of 
well-being and minimal depressive symptoms at baseline. Indeed, the optimal 
score possible was observed at baseline for at least one participant in four of the 
seven variables producing a floor effect in the case of NA and PHQ9, and a ceiling 
effect in the case of well-being QOL and Family/Social QOL.  
In terms of depression, two previous studies have shown a significant decrease in 
depression pre-post GAP. One of these saw a treatment effect relative to a WLC 
(Coote & MacLeod, 2012), meaning treatment effects were over and above any 
effect of spontaneous recovery over time, regression to the mean, or anticipatory 
effect of being in a WLC as mentioned previously as an explanation of the current 
results. However, the study only recruited those reporting clinical levels of 
depressive symptoms at baseline, reducing the likelihood of ceiling effects 
occurring, and potentially reducing the likelihood that those in the WLC could 
address their difficulties by other means. The other GAP study recruited inmates 
with a stable major psychotic illness in secure forensic units where GAP was 
delivered in a facilitated group format, rather than self-help. Mean baseline levels of 
depression were in the mild range, but there was no control group. It is possible 
that a control group would have also seen an improvement for the reasons 
mentioned above, but equally a control group in a forensic setting may not have the 
same levels of motivation as in the current study as they were not required to 
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volunteer in the same way, and therefore may not have shown significant 
improvements.  
In regards to well-being however, in the two studies of GAP that used non-clinical 
populations, (MacLeod et al., 2008; Oliver & MacLeod, 2018), no 
inclusion/exclusion criteria were applied and compared to controls there was still a 
significant increase pre-post in NA, PA and Satisfaction with Life, and in PA and 
Flourishing (but not NA or life satisfaction), respectively. These results suggest that 
a floor/ceiling effect alone is unlikely to account for lack of an effect in terms of well-
being measures in our sample, although it may have reduced power to detect 
differences. 
One factor of interest is the level of guidance provided to participants. In the first 
GAP study that used a non-clinical sample, participants received four supportive, 
structured telephone calls while working through the manual, compared to no 
guidance in the current study. Oliver & MacLeod (2018), however, had a similar 
pure self-help format to the current study, with only 12 of the 170 intervention 
participants opting to receive the telephone guidance that was offered. The 
significant increases in PA and Flourishing observed with small to medium effect 
sizes demonstrating that, with a group of non-clinical working adults, treatment 
effects can be observed without any therapist guidance.  
The issue of how much guidance influences outcomes of SHIs is still debated. 
There have been many studies concluding that increased support or guidance 
results in better outcomes, however, this notion has been challenged by a meta-
analysis that did not show a significant difference in outcome between pure-self-
help, minimal contact, or guided SFIs (Farrand & Woodford, 2013). For people with 
MS, although the number of studies is small, there does appear to be a trend 
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towards improved outcomes with increased guidance, as discussed in the previous 
chapter. For example, the Invigor8 intervention saw the largest effect size when 
delivered face-to-face; effect sizes reduced slightly in an SHI format when 
accompanied by telephone support, reduced further with email support, and were 
smallest with no support (Moss-Morris et al., 2012; van Kessel et al., 2016). Also, 
an automated CBT SHI found higher effect sizes in a subgroup of participants that 
received one face-to-face assessment appointment in addition to the SFI, 
compared to the whole sample (Fischer et al., 2015). 
Although GAP has maintained effectiveness in a pure SHI format with working 
adults, it is possible that this format falls short of being effective for people with MS. 
The absence of contact with a ‘therapist’ may have contributed to a lack of 
commitment and motivation, seen by reduced viewings of the modules as time 
went on, or to a reduced efficacy due to individuals not following the content as 
intended. Indeed, past studies of GAP showing the largest treatment effect sizes 
were the ones with the most guidance.  
The absence of therapist contact may also decrease efficacy by a lack of feedback, 
as goal-setting theory proposes that people need feedback to track their goal 
progress (Locke & Latham, 1990). Although the program aims to teach the user in 
setting manageable self-concordant approach goals, it is possible that further 
guidance through this process was needed at the beginning of the program, as in 
previous studies, as goals chosen in modules 1 and 2 are used throughout the 
remainder of the program. If goals were too broad or unattainable participants 
would be less likely to experience an increase in well-being through anticipatory 
affect or goal progress, and if chosen goals were extrinsically motivated they would 
be unlikely to lead to an increase in well-being, and could even lead to decreases 
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in well-being (Brunstein, Schultheiss, & Grässman, 1998). The association 
between approach goals, avoidance goals and well-being, is complicated because 
all goals sit within a hierarchy of motivations and other goals, and for this reason 
guidance for some people at the goal setting stage may be required (MacLeod, 
2013). As eluded to earlier, the need for guidance may be further indicated in the 
presence of MS-related symptoms discussed below. 
MS-related factors. Baseline scores on the thinking and fatigue subscale of the 
FAMS indicated that some of our sample had problems with cognitive functioning. 
The nine items on this subscale refer to the impact of decreased cognitive 
functioning and fatigue such as “I have trouble starting things because I am tired”, 
“I have trouble concentrating”, “I have trouble learning new tasks or directions”.  
Every participant indorsed at least four statements, and 15 (26%) reported 
experiencing all nine statements ‘quite a bit’ or ‘very much’ in the past seven days. 
As mentioned earlier, the mean scores on this subscale indicate greater impact 
than those reported in other samples of people with MS (Cella et al., 1996). It is 
possible that the impact of cognitive symptoms and fatigue reduced the ability for 
participants to engage fully with the modules and practice during the week. 
Another factor to consider is that people with MS face considerable challenges in 
day to day functioning that could interfere with goal pursuit; this was one reason 
that such an intervention was thought to be of potential benefit to people with MS. 
Dodge and colleagues define well-being as the balance point between an 
individual’s resource pool and the challenges faced (Dodge, Daly, Huyton, & 
Sanders, 2012). GAP aims to increase individuals’ internal resources concerning 
goal pursuit and planning; however, the increase may not be enough to increase 
well-being when the challenges posed by MS are significant. Specifically, GAP 
98 
 
aims to support individuals in experiencing progress in subjectively important goals 
using planning skills and guidance, and also to abandon, adapt or substitute 
unachievable goals. Both these processes of assimilating and accommodating are 
crucial in the link between having important goals and increased well-being. While 
the guidance in GAP modules may be sufficient for community samples to do this, 
people with MS may require additional guidance in this process due to the 
increased restrictions and challenges posed by MS and requiring more adapting 
and substituting of goals.  
Attrition and Adherence  
The low interest and uptake of the study in this population are notable. It is hard to 
know precisely how many individuals saw information about the study, but the 
number is likely to be over one thousand based on the membership numbers of MS 
Centres that circulated the study advert via email and the number of followers of 
the MS Charities that shared it on social media. Only 264 of those who saw the 
advert clicked on the link to view the PIS, and of those only 62 consented; this is a 
considerably lower response rate than seen in other populations for the same 
intervention (e.g. 31% for those with depression (Coote & MacLeod, 2012)). It may 
suggest that people with MS feel that it is not going to be helpful or perhaps feel 
they do not have the energy needed to commit to a longitudinal study. 
The 20% attrition seen at both Time 1 and Time 2 is comparable to other studies of 
SHIs of people with MS, which is lower than that of other populations using SHIs, 
as described in the previous chapter. For example, the studies of pure self-help 
interventions identified in the systematic review had attrition rates of between 19% 
and 55% (Fischer et al., 2015; Pöttgen et al., 2018; van Kessel et al., 2016).  
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In regards specifically to PPI self-help interventions, none were identified for people 
with MS in the systematic review.  However, a study of PPI strategies in a pure 
online self-help format in a non-clinical population found attrition rates of around 
50% (Schueller & Parks, 2012). In the current study, there was greater attrition in 
the intervention group than the control group. This could be due to the nature of the 
intervention, potentially being perceived as too great a commitment, unmanageable 
in the context of living with MS, or perhaps, unhelpful. Another contributing factor 
could have been differences between groups, unaccounted for by randomisation. 
The intervention group had a significantly longer disease duration than the control 
group, and in line with a longer disease duration, had a trend towards older mean 
age and greater proportion of secondary-progressive subtype than relapsing-
remitting subtype. Progressive subtypes of MS are associated with greater 
symptoms, including cognitive impairment (Huijbregts, Kalkers, de Sonneville, de 
Groot, & Polman, 2006), so it is possible that participants in the intervention group 
were affected by MS-related symptoms and these symptoms increased the 
likelihood of dropping out. A larger sample size would be less likely to have any 
significant differences between groups after randomisation. 
In terms of adherence, sixty-eight percent of participants in the current study 
accessed half the modules; similar to other SHI studies using MS samples as 
identified in the systematic review, and similar to working adults using pure self-
help GAP (Oliver & MacLeod, 2018). This adherence figure is substantially lower 
than the average for SHIs. For example, a meta-analysis of computerised CBT 
found that on average, 80% of people completed all stages (Andrews et al., 2010). 
The discrepancy in both attrition and adherence to SHIs suggests that people with 
MS find it more difficult than other populations to adhere to the full course of an 
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SHI, and that GAP may need changes to improve adherence. A weakness in our 
website analytic data is that it only tells us the numbers that accessed the modules 
and not how many completed it; so although 68% accessed Module 3, the 
proportion that completed it could be substantially less. 
There have been some studies evaluating SHIs for people with MS, however, that 
have found high adherence rates. For example, Motl and colleagues reported 97% 
adherence to a computerised guided SHI (Motl et al., 2017). The intervention 
included interactive video courses which could have increased engagement in the 
content, and participants received guidance through skype support, which is likely 
to have had an impact on commitment. 85% of their sample had RRMS, compared 
to 53% if this sample, which could have meant that they were less impacted by 
symptoms and more able to engage in an intervention. Also, over 80% of people 
who contacted the study were excluded due to not meeting inclusion/exclusion 
criteria such as being relapse free in the past 30 days and being non-active during 
the past six months, meaning only those most likely to benefit from the intervention 
were included.  
Limitations 
In spite of its original contributions, there were several limitations to this study. 
Firstly, the small sample size. Only medium to large effect sizes could be detected 
in the ITT analysis, and due to missing data, only large to very-large effect sizes 
could be detected in the modified ITT analysis; this means possible small to 
medium treatment effects may have been unidentified. Recruitment was sought 
only through charitable organisations and not clinical settings, which could have 
resulted in a sample that is not wholly representative of the population of people 
with MS. The study sample was comparable to reported national epidemiological 
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estimates in terms of age, gender distribution and MS subtypes distribution 
(National Multiple Sclerosis Society, n.d.), but the current sample may have 
differed on variables that were not measured, such as level of disability, income or 
employment.  
The study relied on self-report of a MS diagnosis rather than medical records, 
which means that some participants may have been mistaken either in the 
diagnosis of MS itself, or in the subtype indicated. Due to broad inclusion criteria, 
some participants may have been unable to improve on specific measures, and 
some may have been limited in their capacity to follow the intervention. In 
particular, severe cognitive dysfunction may have presented a barrier to adherence 
and comprehension.  
The website analytics data was not detailed enough to identify which ID numbers 
accessed all of the modules, and so the modified ITT used those that completed all 
outcome measures as a proxy for adherence to the intervention, which could be 
flawed as some people may have completed measures but not the intervention and 
vice versa, skewing results.  
Although the chosen measures in this study have been used in published studies 
with samples of people with MS previously, the I-PANAS and the Flourishing Scale 
have not been validated specifically for use in people with MS. It is possible, 
therefore, that certain variables related to MS could affect how accurately these 
questionnaires measure state affect and flourishing, respectively.  
Implications 
Our results suggest that GAP intervention could be used to improve the social 
aspect of well-being for those that adhere to the program. There is no evidence 
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that other aspects of well-being such as affect, flourishing, and satisfaction in life 
are improved in this population. The lack of clear benefits in other areas of well-
being raises the question of how clinically meaningful improvement in social well-
being is for people with MS in isolation. Research shows that the life goal of 
intimacy is rated as 'extremely' important, is the most important goal for people with 
neurological disorders, and that they rate it as significantly more important than 
healthy controls do (Conrad, Doering, Rief, & Exner, 2010). Intimacy is also seen 
as the most attainable and favourable life goal. The importance placed on social 
well-being does suggest that an intervention that could help improve the perceived 
quality of one's relationships would be worthwhile for people with MS. Although 
worth investigating further, further research is needed before recommendations 
could be made to use GAP in the population of people with MS due to factors 
outlined in the limitations section. 
Future research 
Future research could involve qualitative investigation to find a) how GAP could be 
made more appealing to people with MS to increase uptake and recruitment, and 
b) what changes could be made to make GAP more helpful for people with MS. 
Further improvements could be made to aid adherence and commitment by using 
multimedia, providing regular reminders by email, and providing telephone 
guidance at critical points such as choosing a goal to work on during the 
intervention and making adaptations or replacing goals that turn out to be 
unattainable. Measures that identify levels of cognitive impairment could be used 
so that any moderating effects on treatment effects could be seen, while still being 
inclusive. Finally, it would be helpful for future studies to set up analytics in such a 
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way that individual user adherence could be tracked to aid sensitivity analysis.
  
Conclusion 
This study aimed to determine whether an online goal-setting and action-planning 
self-help intervention could improve well-being and reduce depression in people 
with MS. The intervention was delivered in a pure self-help format in the hope that, 
if it proved effective, it could be made available to more adults with MS as a low-
cost, accessible well-being initiative.  
The study did not support the hypothesis that GAP can reduce depression in 
people with MS relative to controls because although depressive symptoms 
improved over time for the intervention group, similar improvement was seen in the 
WLC group. An explanation could be sought in spontaneous recovery of a highly 
motivated subsample of patients. Concerning well-being, results suggest that for 
those that adhere to at least three modules, this intervention can significantly 
improve individual’s well-being in the domain of family and social relationships 
relative to controls and that this improvement is maintained over time. The finding 
of no treatment effects relative to controls on other measures of well-being could 
be attributable to low power because small effect sizes were found in favour of the 
intervention group for all measures except NA. Alternatively, the intervention may 
not be effective enough in a pure self-help form to increase well-being in other 
domains for people with MS; the additional challenges posed by MS in the pursuit 
and adaptation of goals could mean they require additional guidance in the process 
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Integration, impact, and dissemination 
 
Integration 
The overall aim of the current research was to investigate if SHIs could be used to 
improve well-being for people with MS, and specifically, whether an SHI that 
teaches goal-setting and planning skills could improve well-being in people with 
MS. To gain an understanding of what kind of SHIs have already been evaluated in 
populations of people with MS and how effective they are, a systematic review was 
conducted. Following this, an RCT was conducted to evaluate the efficacy of an 
established SHI that teaches goal-setting and planning skills at improving well-
being using a sample of people with MS. 
The systematic review explored the effectiveness of SHIs for increasing well-being 
and reducing distress for people with MS. Although SHIs are well evidenced in 
many populations, results from the systematic review highlighted the paucity of 
research in the MS populations. Results were mixed in terms of efficacy and 
suggested that they could be beneficial, but it was difficult to determine what 
features were related to greater treatment effect. The review revealed a trend 
towards difficulty in supporting adherence to self-help interventions, especially if 
therapist guidance was minimal.  The paucity of studies found in the systematic 
review confirmed the belief that SHIs for people with MS is an area that requires 
further research and gives value to the empirical study. It was surprising that the 
systematic review did not result in a single study investigating an SHI aimed to 
improve well-being, considering that this was the primary interest. Again, this gave 
value to the empirical study in that it appeared to be the first of its kind. Finding no 
studies of PPI SHIs in the systematic review, however, posed a problem that the 
results of the review did not provide a full context for the results of the empirical 
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paper to be formulated within. Although the results of the empirical study could be 
compared to the results of those included in the review in terms of intervention 
methodology such as participants characteristics, format and level of guidance 
given, a comparison could not be made in terms of the content of the intervention. 
The combined results highlighted the need for future research to address the 
extent to which the different SHI approaches and techniques are responsible for 
improvements in outcomes and establishing who responds best to the 
interventions. 
In addition, the limitations found in the studies in the review helped to inform the 
empirical study. For example, most studies used a health-related QOL measure 
which have an exclusive focus on symptomatology, which limits the understanding 
they provide, as research shows that treating depression in people with MS 
influences both the negative and positive aspects of QOL. For the empirical study, 
an MS-specific QOL measure was selected that included positive aspects of quality 
of life such as feeling supported, accepting one's illness and enjoying activities, as 
well as the negative impact of physical health symptomatology. Results also 
underscored the importance of examining well-being with two or more 
complementary approaches, which was achieved in the empirical study by 
including a measure of flourishing as well as the more traditional well-being 
measures of satisfaction in life, measured by the FAMS, and affect, measured by 
the PANAS-SF. Another issue that was encountered was that some studies did not 
report effect sizes, which made it difficult to make comparisons between studies 
with different sample sizes. In the empirical study, effect sizes were reported for all 
possible results so that comparisons could more easily be made. For some studies 
identified in the systematic review, a risk of bias was introduced through using 
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case-wise deletion instead of ITT analysis, and so procedures were used to allow a 
primary ITT analysis in the empirical study. 
Securing sample sizes large enough to meet power requirements was a point 
identified that would substantially improve the quality of evidence for future 
research. Unfortunately, despite the considerable effort, I was unable to attain a 
large enough sample size to allow for dropouts. It was also beyond the scope of 
this thesis to collect data from those who declined to participate to see how these 
individuals differ to those that participated and to gather information to improve the 
desirability of the GAP intervention. Difficulties concerning recruitment are further 
discussed in the following section. 
Research Challenges and their Implications for the Project 
Recruitment. Recruitment and retention of participants in research are serious 
methodological concerns because sufficient sample size is required to ensure 
adequate statistical power (High 2001) and for the avoidance of Type II error (Drew 
et al. 2002) and high attrition can influence the validity of the research findings. 
Despite the widely recognised importance, only 31% of RCTs reach their 
recruitment target (McDonald et al., 2006). The aim for the empirical study was to 
recruit a minimum of 62 participants, as identified by the a priori power calculation 
of 52 and accounting for an expected 15% attrition and was hoping to recruit 
substantially more. The final sample was 58, and more than expected participants 
dropped-out, in the intervention group particularly, meaning overall, only 46 
participants had complete cases at all three time points.  
Recruitment for the empirical study started early, and active recruitment ceased not 
because of time restraint as often occurs but because of using up all available 
avenues. I now wonder if a larger sample would have been possible to acquire if I 
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had applied for NHS ethical approval. A deliberate decision to only seek rhul ethical 
approval and not NHS was made for two reasons. Firstly, the RCT and longitudinal 
design of my study required a substantial study period, and therefore recruitment 
had to start and finish promptly; waiting for NHS ethics approval could have 
delayed the study start and risked running out of time to write up. Secondly, I 
believed that, as there were many non-NHS organisations involved with supporting 
people with MS, there would be a sufficient pool of people to recruit from. However, 
I overestimated what the response rate would be. Despite 57 MS Centres and 
support groups circulating the study advert to their members, many of which had 
100+ members, and three major MS charities publishing the study advert on their 
social media (who have over 60,000 combined followers), only 264 people viewed 
the online PIS. Although it is impossible to say precisely how many people saw and 
read the study advert and therefore what proportion responded, it is almost 
certainly substantially less than 10% and fair to say reflects a low level of interest. 
Furthermore, only 61, 23% of those who viewed the PIS, then decided to consent 
and take part. The low response rate was disappointing, especially after the 
successful recruitment of so many MS Centres. 
The GAP intervention has struggled to gauge interest in previous studies, but to a 
lesser extent. For example, in Oliver and MacLeod’s recent study the advert was 
circulated to 4000 working adults of whom 335 viewed the PIS (8.4%), and 330 of 
those then consented (98%). It is maybe not surprising that a lower response rate 
would occur in the current population considering that physical limitations such as 
tiredness and ill health are one of the most frequently cited reasons for refusal to 
participate and withdrawal from a study (Gul & Ali, 2010). In other studies that have 
recruited MS samples for SHIs, many do not report the recruitment process in 
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enough detail to ascertain response rate, a factor that could be improved in future 
reporting of studies. In those that have, the response rate has varied. Two studies 
used similar recruitment strategies as the current study. Moss-Morris and 
colleagues advertised on MS Society and MS Trust websites and a press release 
in the UK over 61 days had 112 people respond. Boeschoton and colleagues who 
invited people through MS centres and websites in the Netherlands took four years 
to reach 495 respondents. Others used a combination of clinical and non-clinical 
recruitment methods. Fischer and colleagues mailed 2,904 people from an MS 
outpatient clinic database in Germany in addition to online forums, and 241 
responded (8.3%), and Pöttgen advertised on MS organisation websites in 
Germany and via newsletter and leaflet distribution at an outpatient clinic over 140 
days and received 531 responses. 
With retrospection, it may have been better to have used a pre-post RCT design 
with no follow-up, which would have relieved time pressure and allowed for NHS 
ethical approval and new recruitment from clinical settings. The difficulty in 
recruiting participants does also raise questions about the usefulness of GAP for 
people with MS, although it may be less daunting and more desirable as an SHI 
outside of a longitudinal study. 
Attrition and missing data. Some attrition is bound to occur in applied research, 
especially when a follow-up period is involved. The 20.7% observed in the current 
study at post-intervention and follow-up is within the normal reported range for 
RCTs, but bias is still expected in the results when the attrition rate exceeds 20% 
(Dumville, Torgerson, & Hewitt, 2006). Bias is introduced because attrition causes 
alterations in the composition of experimental and control groups and consequently 
affects the internal validity of the study. Furthermore, because we have significantly 
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more participants leaving the intervention group than the WLC group, the likelihood 
that participants in one group are not balanced with similar participants in the other 
trial arm is increased.  
I attempted to address attrition and the subsequent missing data in several ways. 
Firstly, I included a table of comparisons of participants with complete data and 
those with missing data on all baseline variables, as recommended in the literature 
(Dumville et al., 2006). Comparison through statistical analysis revealed that there 
were no significant differences between the two groups, which gave some 
confidence that the risk of bias was not high. However, Altman and colleagues 
warn that an imbalance of a predictor variable may still bias the study results, even 
if the imbalance does not reach conventional levels of significance (Altman, 1985). 
I noted that those with missing data on average were older, had a longer disease 
duration, had secondary-progressive type of MS which is associated with more 
disability than relapsing-remitting type, and had lower QOL in the domains of 
mobility and symptoms than those who had completed measures at every time 
point.  
Secondly, I used MI in order to allow for an ITT approach for primary analysis, and 
I imputed missing scores separately for Intervention group and WLC group, which 
produces unbiased results when there is a possible interaction effect involving the 
randomised groups. Although this is a method used to reduce bias introduced 
through missing data, it is likely that some bias remained. Despite some of the 
limitations described, the results from the thesis have advanced the understanding 
of SHIs for people with MS and have implications for future research. 
Impact 
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The findings overall of this thesis have highlighted a significant need for well-being 
interventions to be evaluated in people with MS. The systematic review revealed 
that there were very few SHIs evaluated in people with MS, and none that were 
designed to increase well-being or to reduce anxiety. The mixed findings from the 
studies in the systematic review and the empirical study show that although some 
SHIs can be useful for people with MS, effort needs to be put into understanding 
the factors associated with effectiveness so that they can be incorporated into the 
design of future SHIs. The use of online formats has opened up a host of different 
content options in interventions such as videos, audio, skype therapist support, 
automated feedback, automated reminders, and interactive interface in which the 
module content is adapted based on the users’ feedback to questions. The studies 
identified in the systematic review used different combinations of these techniques, 
making it difficult to compare the impact of any one technique directly. There are 
also techniques that have not yet been utilised in SHIs for people with MS, for 
example encouraging social contact between users to discuss progress in online 
learning groups could help increase motivation and provide peer support which is 
positively associated with perceived physical and mental health status in MS 
patients (Krokavcova et al., 2008).  
The empirical study evaluated a self-help format of a well-established well-being 
intervention which enabled comparison of results to those of previously published 
studies of the same intervention with different populations. The demonstration of 
efficacy in other populations allowed some confidence that the lack of treatment 
effect in the primary analyses, if not a Type II error, was due to factors associated 
with MS and not that the intervention is ineffective in isolation. The fact that an 
intervention that has been shown to increase well-being in various populations was 
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less effective in a sample of people with MS highlights the different needs people 
with MS have and the importance of even well-established interventions to be 
evaluated in this population before being recommended. It also gives support to the 
idea of interventions being designed collaboratively with people with MS from the 
early stages, rather than adapting interventions that have already been designed 
for use in other populations. Collaboration between people with MS and 
professionals is an area that has only recently been championed, with initiatives 
such as the Multiple Sclerosis in the 21st-century group bringing the groups 
together to form shared understandings and shared decisions for future research to 
improve patient outcome (Rieckmann et al., 2018).   
The current project will raise awareness of mental health and well-being for people 
with MS in the community, an area that people with MS identify as an unmet need 
in current society (Rieckmann et al., 2018). The study supported the knowledge in 
the literature that many people with MS report clinically relevant depressive 
symptoms and lower levels of well-being than the general population, and this is 
pertinent to professionals working with people with MS. Professionals should be 
asking about mental health and can use depression screening questionnaires and 
well-being questionnaires to open up conversations. 
The points raised from this thesis are relevant to the research community, who can 
take the lead on building our currently limited knowledge of how to help increase 
well-being and reduce distress for people with MS.  To further knowledge in the 
field, it will require: collaboration and input from people with MS; the evaluation and 
subsequent adaptation of interventions known to be effective in other populations; 
the incorporation of qualitative information into study designs; and the use of 
experimental methods to identify optimal factors associated with effectiveness. 
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Dissemination 
One aim of making the results of this widely available is to encourage engagement 
in and promote the need for research into self-help interventions for people with 
MS. The first stage of the dissemination strategy involves providing a plain English 
summary of the research findings to those who participated in the study, as 
interaction with the end-user is key to the successful dissemination of findings 
(Wilson, Petticrew, Calnan, & Nazareth, 2010). The PIS and email correspondence 
stated that participants would receive a summary of the findings via email unless 
they would prefer not to, and as no one opted out, all participants will be sent one. 
The fact that no participants opted out, and indeed several people responded 
saying that they would appreciate knowing the results, is a testament to the value 
of this part of the strategy. The plain English summary will be written by me with 
collaboration with my supervisor, Professor Andy MacLeod, and agreed upon 
before sharing with participants. As the results of the study may be disappointing 
for participants to hear, the wording is especially important so as not to have any 
negative impact.  
A version of the plain English summary will also be given to the contact staff 
member of all participating MS Centres and MS support groups. Dissemination to 
staff members will be an essential step as staff members at centres can then 
become sources of continued dissemination themselves, which may have a more 
significant impact than when coming from the researchers (Petty, Gleicher, & 
Jarvis, 1993). 
The main message that I will be aiming to communicate is that efforts should be 
made to open up conversations about mental health and well-being for people with 
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MS and that the research community need to collaborate with people with MS to 
create and evaluate psychological interventions for people with MS. A focus on 
self-help interventions that can be accessed remotely and require minimal therapist 
contact time, thereby making them accessible for large amounts of people, is 
especially important.  
Channels of communication will include direct emails to participants, emails to 
contact staff members at MS Centres and support groups, pieces in individual MS 
Centre newsletters and social media, and a piece in the MS National Therapy 
Centres (MSNTC) charity newsletter and social media. Beyond the immediate 
participants and recruitment sites, dissemination to a broader audience involves 
traditional publication routes through submission of both the systematic review and 
empirical project to established MS and well-being journals. 
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